Hypokalaemia

E4_HYPOKALAEMIA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E87.6 Hospital discharge: ICD-9 — 2768 Hospital discharge: ICD-8 — 78891 Cause of death: ICD-10 — E87.6 Cause of death: ICD-9 — 2768 Cause of death: ICD-8 — 78891 2 out of 7 registries used, show all original rules.	4780
4. Check minimum number of events None	4780
5. Include endpoints None	4780
6. Filter based on genotype QC (FinnGen only)	4780

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E87
Name in latin: Hypokalaemia

NAME	E4_HYPOKALAEMIA
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E876
HD_ICD_9	2768
HD_ICD_8	78891
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E876
COD_ICD_9	2768
COD_ICD_8	78891
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypokalaemia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	44509	28754	15405
Only index persons	37186	24295	12891
Unadjusted period prevalence (%)
Whole population	0.68	0.82	0.43
Only index persons	0.75	0.89	0.49
Median age at first event (years)
Whole population	68.02	70.70	63.06
Only index persons	67.64	70.04	63.12

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4780	2992	1788
Unadjusted period prevalence (%)	0.93	1.02	0.79
Median age at first event (years)	64.85	63.92	66.41

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4218: Matched controls
42180

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

121.4

323.0

716

E87.6

ICD-10 Finland

Hypokalaemia

8875.9

323.0

4065

105

C03DA01

ATC

spironolactone; oral

6.2

323.0

1104

2285

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

7.7

260.5

655

987

C03CA01

ATC

furosemide; systemic

3.2

251.9

1840

8143

E86

ICD-10 Finland

Volume depletion

80.2

245.3

277

I10

ICD-10 Finland

Essential (primary) hypertension

2.8

213.0

2882

18270

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.7

203.8

1071

3571

AA1AD

NOMESCO Finland

CT of head and brain

3.1

198.6

1407

5859

R53

ICD-10 Finland

Malaise and fatigue

3.3

195.8

1255

4856

C08CA01

ATC

amlodipine; oral

2.7

190.1

1920

9953

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

179.9

2176

12371

A12BA01

ATC

potassium chloride; oral

6.0

178.2

530

981

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.5

168.6

919

3095

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

164.7

1558

7593

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.2

155.7

957

3506

C07AB07

ATC

bisoprolol; oral

2.4

152.1

2301

14217

R11

ICD-10 Finland

Nausea and vomiting

4.4

150.5

602

1534

205

Kela drug reimbursment

Chronic hypertension

2.5

146.0

1565

8045

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.6

139.1

1284

6044

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.7

138.2

684

2101

N05AH04

ATC

quetiapine; oral

3.1

137.7

899

3402

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

135.9

1113

4871

N17.9

ICD-10 Finland

Acute renal failure, unspecified

7.3

132.5

336

494

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.5

131.7

696

2247

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

9.2

123.9

270

311

I50.9

ICD-10 Finland

Heart failure, unspecified

3.0

122.6

830

3190

A02BC02

ATC

pantoprazole; systemic

2.2

121.5

2885

20936

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

6.5

121.0

333

548

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.6

118.7

1022

4552

N06AX11

ATC

mirtazapine; oral

2.3

116.3

1546

8607

R56.8

ICD-10 Finland

Other and unspecified convulsions

5.4

114.9

368

731

E87.5

ICD-10 Finland

Hyperkalaemia

34.0

114.8

151

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

113.6

1515

8426

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

111.5

735

2759

F10.25

ICD-10 Finland

Alcohol dependence continuous use

11.6

109.2

209

188

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.2

108.5

634

2185

2768A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]

+∞

107.8

103

A28

ICPC

Limited function/disability NOS

2.7

104.3

860

3700

SPAT1254

SPAT

Administration of medicine

2.7

99.3

800

3383

E83.51

ICD-10 Finland

Hypocalcemia

175.9

98.7

103

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

98.5

615

2211

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

16.4

97.9

161

102

P15

ICPC

Chronic alcohol abuse

7.3

96.5

243

351

N02AA05

ATC

oxycodone; systemic

2.6

96.4

822

3586

F10.24

ICD-10 Finland

Alcohol depence active use

11.9

95.9

181

158

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

23.6

94.6

137

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

15.1

93.8

159

109

N05BA04

ATC

oxazepam; oral

2.2

93.1

1220

6598

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.3

91.9

300

606

N05CF01

ATC

zopiclone; oral

2.0

91.2

1583

9625

A06AD11

ATC

lactulose; oral

2.5

90.6

816

3657

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.3

89.1

507

1698

L28

ICPC

Limited function/disability (L)

2.5

86.4

823

3791

F10.20

ICD-10 Finland

Alcohol dependence currently independent

8.6

86.0

194

236

N07BB01

ATC

disulfiram; oral

4.9

84.4

291

623

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

82.6

825

3882

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.5

82.4

752

3375

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.2

82.0

1051

5572

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

81.6

812

3812

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.6

81.5

686

2944

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

81.1

711

3121

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

13.4

79.8

142

109

N06AB04

ATC

citalopram; systemic

2.2

79.5

1049

5622

R06.0

ICD-10 Finland

Dyspnoea

2.1

79.4

1135

6295

E26.0

ICD-10 Finland

Primary hyperaldosteronism

20.5

78.2

118

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

78.0

769

3585

WX892

NOMESCO Finland

Monitored bed care

3.4

77.6

413

1310

C03AA03

ATC

hydrochlorothiazide; oral

2.7

77.5

581

2324

C08CA13

ATC

lercanidipine; oral

2.5

77.3

682

2996

JN3AD

NOMESCO Finland

Abdominal CT examination

3.2

76.0

438

1471

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

9.3

76.0

163

182

UJF32

NOMESCO Finland

Coloscopy

2.0

74.7

1191

6873

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

74.7

1176

6753

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

74.2

516

1966

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

8.8

73.9

164

194

N02AX02

ATC

tramadol; systemic, rectal

1.8

73.9

1840

12488

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

73.5

1478

9302

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

10.4

72.5

146

145

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

72.5

1582

10238

N03AX16

ATC

pregabalin; oral

2.0

70.0

1064

5998

A46

ICD-10 Finland

Erysipelas

2.4

69.9

682

3143

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.4

69.8

221

429

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

12.2

69.5

129

109

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

69.0

1006

5568

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.0

68.3

1070

6096

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

67.4

690

3253

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

67.1

915

4917

N02BE01

ATC

paracetamol; systemic, rectal

2.0

67.0

3566

30700

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

337.4

66.7

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

65.8

553

2350

R60.0

ICD-10 Finland

Localized oedema

2.5

65.0

589

2607

H02AB06

ATC

prednisolone; systemic

1.7

63.9

1965

14046

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.8

63.7

284

777

J01MA02

ATC

ciprofloxacin; systemic

1.8

63.6

1661

11273

SPAT1262

SPAT

Handing over of treatment supplies

2.1

62.8

807

4212

N05BA01

ATC

diazepam; systemic, rectal

2.3

62.2

682

3314

F10.09

ICD-10 Finland

Alcohol intoxication UNS

6.8

62.2

162

245

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.5

62.1

315

958

R55

ICD-10 Finland

Syncope and collapse

2.5

62.1

538

2319

78891

ICD-8 Finland

Other general symptoms, Hypokaliaemia

+∞

61.6

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

61.1

398

1446

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.4

60.7

314

970

E87.2

ICD-10 Finland

Acidosis

+∞

60.6

TKC20

NOMESCO Finland

Catheterisation of bladder

3.0

60.0

379

1349

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.3

58.1

316

1013

C10AA01

ATC

simvastatin; oral

1.7

57.6

1726

12107

C02AC05

ATC

moxonidine; oral

3.8

57.1

260

723

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.0

57.0

348

1211

N06AX16

ATC

venlafaxine; oral

2.3

56.9

582

2726

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

56.7

978

5716

S06.0

ICD-10 Finland

Concussion

2.5

56.3

487

2092

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

56.3

861

4806

C01DA14

ATC

isosorbide mononitrate; oral

2.2

56.2

671

3375

A04

ICPC

Weakness/tiredness general

2.3

56.2

610

2937

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

55.8

795

4310

C07AB02

ATC

metoprolol; systemic

1.9

55.5

965

5649

R42

ICD-10 Finland

Dizziness and giddiness

1.9

55.3

975

5737

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.7

55.0

421

1688

R41.0

ICD-10 Finland

Disorientation, unspecified

4.5

54.8

205

476

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

54.7

379

1431

N05AA02

ATC

levomepromazine; systemic

3.8

54.6

244

668

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

9.2

54.3

116

129

R50.9

ICD-10 Finland

Fever, unspecified

2.2

54.2

612

2998

J01DB01

ATC

cefalexin; oral

1.8

54.1

3268

27824

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.7

53.3

190

420

H02AB09

ATC

hydrocortisone; systemic

6.0

53.3

153

264

P16

ICPC

Acute alcohol abuse

8.4

53.3

120

146

N05CD07

ATC

temazepam; oral

2.1

53.2

648

3284

I50.0

ICD-10 Finland

Congestive heart failure

2.7

53.2

382

1474

C09AA05

ATC

ramipril; oral

1.8

53.0

1050

6419

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

52.9

1095

6792

J01MA12

ATC

levofloxacin; systemic

2.0

52.3

816

4571

A10AE04

ATC

insulin glargine; parenteral

2.7

52.2

394

1565

M04AA01

ATC

allopurinol; systemic

2.2

51.9

581

2831

K92.0

ICD-10 Finland

Haematemesis

4.9

50.9

174

368

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

50.4

944

5646

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.9

50.1

322

1154

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.2

50.0

279

910

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.7

49.7

360

1392

N30.0

ICD-10 Finland

Acute cystitis

2.1

49.3

643

3347

B01AB05

ATC

enoxaparin; parenteral

1.7

49.2

1271

8421

R51.80

ICD-10 Finland

Headache

2.2

48.2

577

2891

K70.1

ICD-10 Finland

Alcoholic hepatitis

15.8

47.9

N05AH03

ATC

olanzapine; systemic

3.1

47.3

275

922

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

47.0

751

4225

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

76.8

47.0

N06AB10

ATC

escitalopram; oral

1.9

46.9

764

4331

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

46.7

373

1526

E83.50

ICD-10 Finland

Hypercalcemia

19.5

46.6

J01FF01

ATC

clindamycin; systemic

1.8

46.6

1089

6975

SPAT1216

SPAT

Assessment of functional ability

2.0

46.4

724

4037

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

46.4

712

3944

C09AA02

ATC

enalapril; systemic

1.8

46.4

879

5256

N03AG01

ATC

valproic acid; systemic, rectal

3.0

46.2

288

1014

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

46.1

804

4669

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

45.9

755

4292

SPAT1263

SPAT

Sampling

1.6

45.8

1701

12413

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.6

45.3

165

373

N06AX21

ATC

duloxetine; oral

2.3

45.2

457

2111

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

13.6

45.2

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

9.3

44.9

104

T90

ICPC

Diabetes non-insulin dependent

1.8

44.8

909

5550

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

44.7

1074

6924

ZX120

NOMESCO Finland

Intravenous

2.4

44.3

426

1919

C10AA05

ATC

atorvastatin; oral

1.7

44.3

1395

9716

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.8

44.3

198

542

N06AB03

ATC

fluoxetine; oral

2.1

43.8

553

2828

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

7.9

43.7

102

132

R03BB04

ATC

tiotropium bromide; inhalant

2.3

43.7

445

2066

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.4

43.6

226

697

C09CA01

ATC

losartan; oral

1.7

43.3

1008

6424

N03AX12

ATC

gabapentin; oral

2.0

43.1

649

3559

SPAT1234

SPAT

Support of social functional capacity

2.9

42.9

279

1008

N05BA02

ATC

chlordiazepoxide; systemic

4.4

42.9

163

385

A02BC01

ATC

omeprazole; systemic

1.7

42.9

1163

7753

N06AB06

ATC

sertraline; oral

2.3

42.8

451

2125

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

42.7

1248

8496

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.0

42.7

179

463

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

42.7

400

1779

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

42.7

326

1298

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.6

42.2

197

559

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.5

41.7

207

617

N06AA09

ATC

amitriptyline; systemic

2.2

41.6

473

2309

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

12.3

41.5

N19

ICD-10 Finland

Unspecified kidney failure

3.8

41.4

183

496

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

41.4

495

2468

S97

ICPC

Chronic ulcer skin

2.8

41.3

278

1027

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.1

41.2

166

414

SPAT1301

SPAT

No procedures

1.6

41.2

1294

8966

K59.09

ICD-10 Finland

Constipation, unspecified

2.8

41.0

287

1086

F50.0

ICD-10 Finland

Anorexia nervosa

18.8

40.9

SPAT1229

SPAT

Assessment of need for aid

2.3

40.8

401

1825

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

40.8

1285

8902

207

Kela drug reimbursment

Chronic arrhythmias

1.9

40.8

640

3560

N03AX09

ATC

lamotrigine; oral

3.4

40.7

206

624

JN4BD

NOMESCO Finland

Extensive body CT

2.1

40.6

505

2559

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.1

40.6

231

762

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.5

40.5

329

1357

F50.9

ICD-10 Finland

Eating disorder, unspecified

13.4

40.4

B01AC04

ATC

clopidogrel; oral

2.0

40.3

552

2912

AN1

Coronary angiography

2.2

40.3

446

2149

A10BA02

ATC

metformin; oral

1.7

40.1

1074

7110

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

39.8

624

3468

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.0

39.7

247

867

G72.8

ICD-10 Finland

Other specified myopathies

5.7

39.6

117

210

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

8.8

39.4

100

F05.9

ICD-10 Finland

Delirium, unspecified

5.2

39.3

125

245

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.2

39.1

218

710

C08CA02

ATC

felodipine; oral

2.2

39.0

446

2177

A41.9

ICD-10 Finland

Sepsis, unspecified

3.5

38.9

192

570

C07AA05

ATC

propranolol; systemic

1.8

38.9

760

4557

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

38.8

385

1760

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

38.6

706

4140

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.3

38.5

398

1856

I95.1

ICD-10 Finland

Orthostatic hypotension

3.5

38.4

187

550

K59.1

ICD-10 Finland

Functional diarrhoea

2.9

38.2

247

889

A09AA02

ATC

multienzymes (lipase, protease etc.)

4.7

37.9

132

286

R60.9

ICD-10 Finland

Oedema, unspecified

2.9

37.9

248

899

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

37.8

1499

10963

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.6

37.8

290

1158

E87.3

ICD-10 Finland

Alkalosis

+∞

37.5

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.5

37.5

185

549

S01.0

ICD-10 Finland

Open wound of scalp

2.4

37.3

344

1517

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

37.2

420

2037

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

37.1

417

2018

R33

ICD-10 Finland

Retention of urine

2.4

37.0

326

1404

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

36.9

1102

7486

C03DB01

ATC

amiloride; oral

45.4

36.9

B01AA03

ATC

warfarin; systemic

1.7

36.8

857

5424

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

36.7

312

1317

Z72.1

ICD-10 Finland

Alcohol use

6.6

36.6

148

N18.8

ICD-10 Finland

Other chronic renal failure

4.5

36.5

135

311

R4110

NOMESCO Finland

Physiotherapy

1.7

36.3

1034

6929

N05AX08

ATC

risperidone; systemic

2.3

36.3

361

1652

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

7.5

36.2

118

K70.0

ICD-10 Finland

Alcoholic fatty liver

10.8

36.0

WW500

NOMESCO Finland

Blood transfusion

3.1

36.0

204

670

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.3

35.9

138

330

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

35.9

832

5252

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

35.8

244

905

P01AB01

ATC

metronidazole; oral, rectal

1.5

35.7

1536

11413

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.3

35.7

341

1527

Z51.5

ICD-10 Finland

Palliative care

2.5

35.6

287

1177

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.1

35.5

204

678

C09DA01

ATC

losartan and diuretics; oral

2.1

35.5

462

2382

N03AX14

ATC

levetiracetam; systemic

4.1

35.4

142

354

A11CC03

ATC

alfacalcidol; systemic

4.9

35.3

118

245

M79.6

ICD-10 Finland

Pain in limb

1.6

35.0

1341

9683

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

34.9

541

2983

W19

ICD-10 Finland

Unspecified fall

2.1

34.6

417

2080

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.3

34.6

352

1627

WX002

NOMESCO Finland

Sedation and analgesia

1.7

34.5

800

5045

A02BC05

ATC

esomeprazole; systemic

1.5

34.5

1569

11786

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.4

34.4

172

516

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

34.3

578

3284

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.3

34.3

332

1497

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

34.3

404

1997

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

34.1

280

1158

WX882

NOMESCO Finland

High dependency care

3.9

34.1

146

386

B03BA03

ATC

hydroxocobalamin; parenteral

2.5

34.1

293

1245

N05BA06

ATC

lorazepam; systemic, sublingual

2.6

34.0

255

1004

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

34.0

428

2174

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

22.5

33.9

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.0

33.9

210

733

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

33.4

637

3772

J01EA01

ATC

trimethoprim; systemic

1.6

33.4

1061

7294

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

33.3

815

5214

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

33.3

1716

13219

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.2

33.1

183

593

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

6.2

33.1

150

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.8

33.0

222

819

R4190

NOMESCO Finland

Nutritional therapy

3.6

33.0

154

438

E66.8

ICD-10 Finland

Other obesity

3.0

33.0

195

661

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

32.9

369

1782

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.0

32.9

200

691

JN4AD

NOMESCO Finland

Body CT examination

2.3

32.8

337

1561

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

32.8

357

1702

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

32.7

685

4177

C09BA02

ATC

enalapril and diuretics; systemic

2.2

32.6

371

1802

XF404

NOMESCO Finland

Ambulatory ECG

2.1

32.6

378

1853

SPAT1240

SPAT

Therapeutic discussion

2.1

32.0

372

1825

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

31.9

296

1306

B01AF02

ATC

apixaban; oral

2.1

31.9

412

2114

SPAT1265

SPAT

Breathalyser

8.0

31.8

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

114.2

31.7

F50.2

ICD-10 Finland

Bulimia nervosa

15.0

31.3

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

31.1

319

1477

K92.1

ICD-10 Finland

Melaena

2.6

31.1

240

960

WX872

NOMESCO Finland

Intensive care

2.8

31.1

204

739

I95.9

ICD-10 Finland

Hypotension, unspecified

6.0

31.1

147

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.7

31.0

107

230

E26.9

ICD-10 Finland

Hyperaldosteronism, unspecified

33.6

30.9

K08.3

ICD-10 Finland

Retained dental root

2.3

30.8

297

1336

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.5

30.4

148

436

SPAT1125

SPAT

Stoma care and guidance

4.7

30.4

106

231

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

30.3

421

2221

R02

ICPC

Shortness of breath/dyspnoea

1.9

30.0

467

2571

WX110

NOMESCO Finland

Local anesthesy

1.5

29.8

2524

21343

SPAT1172

SPAT

Guidance concerning hydration

3.6

29.6

138

393

A02BC03

ATC

lansoprazole; oral

1.5

29.5

1148

8244

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

29.5

580

3456

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

29.5

324

1546

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

29.4

1002

6968

E66.00

ICD-10 Finland

Metabolic syndrome

2.8

29.2

199

741

M10.9

ICD-10 Finland

Gout, unspecified

2.4

29.2

266

1161

N05CF02

ATC

zolpidem; oral

1.7

29.1

681

4283

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.2

29.0

155

491

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

28.6

967

6709

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

3.5

28.4

139

411

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.6

28.3

209

816

WZC30

NOMESCO Finland

Teaching

1.8

28.3

503

2899

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

28.3

1135

8195

E83.39

ICD-10 Finland

Other disorder of phosphorus metabolism

+∞

28.1

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.3

28.1

266

1186

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

27.9

309

1482

A02BA02

ATC

ranitidine; systemic

1.6

27.9

817

5458

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

27.9

376

1959

N17.8

ICD-10 Finland

Other acute renal failure

6.4

27.9

117

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.8

27.8

185

676

N03AE01

ATC

clonazepam; systemic

2.3

27.8

264

1179

K70.4

ICD-10 Finland

Alcoholic hepatic failure

15.0

27.7

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

27.6

481

2753

V03AA01

ATC

4.5

27.5

223

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.9

27.4

173

612

R07.3

ICD-10 Finland

Other chest pain

2.0

27.3

364

1887

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

4.3

27.3

103

243

N05AF03

ATC

chlorprothixene; systemic

3.5

27.3

131

382

SPAT1260

SPAT

Consultation of another employee

1.7

27.2

697

4490

P29

ICPC

Psychological sympt/compl other

2.6

27.2

201

785

130

Kela drug reimbursment

Malignant tumour

2.0

27.1

355

1826

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

27.0

265

1200

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

27.0

260

1168

SPAT1255

SPAT

Intravenous administration of medicine

2.2

26.8

275

1273

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.2

26.8

103

248

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.5

26.6

219

909

H02AB07

ATC

prednisone; oral

1.7

26.5

583

3592

N03AX11

ATC

topiramate; oral

3.8

26.3

113

301

I50

ICD-10 Finland

Heart failure

2.9

26.3

162

565

N05BE01

ATC

buspirone; oral

3.2

26.2

140

443

UKC02

NOMESCO Finland

Cystoscopy

1.7

26.2

610

3822

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.7

26.2

116

317

C08CA05

ATC

nifedipine; systemic

2.2

26.1

294

1419

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

26.1

464

2671

M54.5

ICD-10 Finland

Low back pain

1.5

26.1

1172

8640

N06AA12

ATC

doxepin; systemic

2.3

26.1

252

1134

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.0

25.9

152

515

A07AA09

ATC

vancomycin; oral

5.1

25.8

162

N06AX03

ATC

mianserin; oral

2.5

25.7

218

916

E61.2

ICD-10 Finland

Magnesium deficiency

262.2

25.7

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

25.7

567

3496

C03BA11

ATC

indapamide; oral

3.0

25.5

154

531

R03AC02

ATC

salbutamol; inhalant

1.4

25.5

1916

15624

F50.1

ICD-10 Finland

Atypical anorexia nervosa

15.9

25.4

A01

ICPC

Pain general/multiple sites

2.1

25.4

304

1507

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.8

25.2

108

287

C07AG02

ATC

carvedilol; oral

2.2

25.2

258

1192

H02AB04

ATC

methylprednisolone; systemic

1.7

25.1

576

3586

J01MA14

ATC

moxifloxacin; systemic

2.0

25.1

344

1801

SPAT1167

SPAT

Insertion of urinary catheter

2.9

25.1

157

555

J01DA01

ATC

[U] cefalexin; systemic

1.4

25.0

2378

20206

C10AC01

ATC

colestyramine; oral

3.2

24.9

132

416

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

24.9

285

1386

E0000UV

ATC

1.4

24.8

1444

11201

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

24.6

292

1444

K59.0

ICD-10 Finland

Constipation

2.3

24.5

236

1059

C07BB07

ATC

bisoprolol and thiazides; systemic

2.5

24.5

193

782

K56.7

ICD-10 Finland

Ileus, unspecified

4.3

24.5

217

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

24.4

291

1440

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.0

24.4

164

A29

ICPC

General symptom/complaint other

1.8

24.4

436

2511

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

6.7

24.4

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

24.3

316

1623

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.5

24.2

114

328

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.7

24.2

183

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

3.2

24.2

128

403

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

11.4

24.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

24.1

1781

14428

R18

ICD-10 Finland

Ascites

3.9

24.1

102

269

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

13.8

24.0

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.9

24.0

100

260

C08DB01

ATC

diltiazem; oral

2.2

23.9

247

1147

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

23.8

730

4912

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

23.7

1302

9966

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

23.6

442

2585

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

23.6

295

1487

Z71.8

ICD-10 Finland

Other specified counselling

1.5

23.4

811

5620

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.7

23.3

173

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.7

23.2

163

618

M05BA04

ATC

alendronic acid; oral

1.8

23.2

400

2275

N05BA12

ATC

alprazolam; oral

1.8

23.2

394

2229

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

23.2

288

1449

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.4

23.2

211

923

I25.2

ICD-10 Finland

Old myocardial infarction

2.2

23.1

232

1065

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.7

23.0

120

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

8.8

23.0

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

22.9

514

3175

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.1

22.9

131

435

WX730

NOMESCO Finland

Conventional respirator

4.4

22.9

194

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.8

22.9

261

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

22.8

124

399

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

22.8

356

1957

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

22.5

1452

11427

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

22.5

494

3032

F34.1

ICD-10 Finland

Dysthymia

2.9

22.4

138

483

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

13.7

22.2

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

22.1

605

3948

P01

ICPC

Feeling anxious/nervous/tense

2.0

22.1

291

1500

N05AB01

ATC

dixyrazine; systemic

4.8

22.1

156

R10.0

ICD-10 Finland

Acute abdomen

2.9

22.1

134

465

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

22.0

338

1843

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

22.0

699

4738

A10BH01

ATC

sitagliptin; oral

1.9

21.9

343

1884

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.9

21.9

232

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.3

21.8

218

997

BC4WT

NOMESCO Finland

Selective blood sample from adrenal gland with radiological guidance

29.2

21.8

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.6

21.8

116

R06.4

ICD-10 Finland

Hyperventilation

4.2

21.8

199

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.3

21.7

129

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.7

21.7

147

547

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.8

21.7

140

503

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.8

21.6

249

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

21.6

409

2398

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.1

21.6

134

J46

ICD-10 Finland

Status asthmaticus

3.0

21.6

130

448

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

9.4

21.5

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

4.0

21.5

226

C09CA03

ATC

valsartan; oral

1.9

21.3

338

1866

A04AA01

ATC

ondansetron; systemic, rectal

2.0

21.3

274

1400

K86.1

ICD-10 Finland

Other chronic pancreatitis

6.0

21.3

100

H03AA01

ATC

levothyroxine sodium; systemic

1.5

21.2

881

6341

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.2

21.2

111

348

N05AD01

ATC

haloperidol; systemic

2.8

21.2

143

531

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

21.1

238

1150

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.6

21.1

153

592

N05AX12

ATC

aripiprazole; systemic

3.1

21.0

120

398

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

21.0

179

755

F50.3

ICD-10 Finland

Atypical bulimia nervosa

15.6

21.0

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

20.9

261

1317

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.1

20.9

116

380

Z00.8

ICD-10 Finland

Other general examinations

2.1

20.8

255

1277

A10AE05

ATC

insulin detemir; parenteral

2.3

20.7

189

828

A12AA04

ATC

calcium carbonate; oral

4.8

20.7

145

H02AA02

ATC

fludrocortisone; oral

6.2

20.7

N03AF01

ATC

carbamazepine; oral, rectal

2.2

20.7

212

981

EBA00

NOMESCO Finland

Extraction of tooth

1.4

20.6

1118

8488

Z02.7

ICD-10 Finland

Issue of medical certificate

2.1

20.6

231

1112

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.1

20.5

129

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.4

20.5

179

765

X58

ICD-10 Finland

Exposure to other specified factors

1.7

20.5

465

2877

SPAT1104

SPAT

Monitoring of emergency patient

2.0

20.5

264

1350

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

5.1

20.4

130

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

20.4

502

3177

P99

ICPC

Psychological disorders other

3.3

20.4

104

320

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

20.4

230

1112

C07AB03

ATC

atenolol; systemic

2.0

20.4

272

1410

JAH00

NOMESCO Finland

Laparotomy

2.9

20.4

128

454

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

20.3

847

6095

I15.2

ICD-10 Finland

Hypertension secondary to endocrine disorders

22.4

20.3

B01AB10

ATC

tinzaparin; parenteral

2.0

20.3

264

1352

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.5

20.3

160

651

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

20.2

246

1226

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

13.1

20.1

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.1

20.0

236

1163

SPAT1307

SPAT

Psychosocial counselling and guidance

2.3

19.9

181

791

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.2

19.8

184

J01CF05

ATC

flucloxacillin; systemic

2.6

19.8

147

578

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

19.8

1238

9634

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.6

19.7

149

592

C09CA06

ATC

candesartan; oral

1.5

19.7

775

5506

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

19.6

428

2619

J01CA08

ATC

pivmecillinam; oral

1.4

19.4

1545

12525

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

19.3

174

756

Y94.0

ICD-10 Finland

Accident at home

3.5

19.3

259

A99

ICPC

Disease/condition unspecnature/site

1.9

19.1

301

1657

S18

ICPC

Laceration/cut

1.4

19.0

1508

12204

R63.4

ICD-10 Finland

Abnormal weight loss

2.6

18.9

142

562

A07AA02

ATC

nystatin; oral

2.0

18.9

266

1403

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

12.8

18.9

K85

ICD-10 Finland

Acute pancreatitis

3.7

18.8

228

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.1

18.8

184

WX402

NOMESCO Finland

General anaesthesia

1.6

18.8

548

3625

E000001

ATC

1.5

18.7

711

5006

WVA20

NOMESCO Finland

Medicine administration

3.2

18.7

100

320

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.1

18.6

176

N03AX18

ATC

lacosamide; systemic

8.3

18.6

R06AE07

ATC

cetirizine; oral

1.4

18.6

1527

12412

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.3

18.6

180

810

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.2

18.6

196

922

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

12.3

18.5

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.2

18.5

316

A10BH05

ATC

linagliptin; oral

2.3

18.5

175

781

XF402

NOMESCO Finland

ECG with work load test

1.7

18.5

369

2193

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

18.5

294

1625

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.9

18.5

197

SPAT1097

SPAT

Recording of ECG

1.6

18.3

554

3699

K20

ICD-10 Finland

Oesophagitis

3.7

18.3

219

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.5

18.2

250

F32

ICD-10 Finland

Depressive episode

2.3

18.2

175

786

N05AB03

ATC

perphenazine; systemic, rectal

2.5

18.2

144

588

J96.0

ICD-10 Finland

Acute respiratory failure

4.6

18.1

139

A08

ICPC

Swelling

2.3

18.1

174

780

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

18.1

226

1139

R04.0

ICD-10 Finland

Epistaxis

1.9

18.1

262

1402

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

18.0

180

825

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.7

18.0

131

I20.09

ICD-10 Finland

Unstable angina

2.2

17.9

186

866

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.3

17.9

176

800

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.0

17.8

220

1106

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

17.7

397

2446

R52.9

ICD-10 Finland

Pain, unspecified

1.8

17.7

300

1695

SPAT1252

SPAT

Overall medication plan or its review

1.9

17.7

280

1547

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.5

17.6

236

R63.0

ICD-10 Finland

Anorexia

8.5

17.6

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

6.6

17.6

ZXA00

NOMESCO Finland

Right side

1.4

17.6

1001

7628

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.3

17.6

268

C01AA05

ATC

digoxin; systemic

1.8

17.6

340

2005

SPAT1310

SPAT

Counselling related to known health issue

1.4

17.5

1140

8896

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.8

17.5

116

427

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.5

17.5

243

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

17.5

147

617

N17

ICPC

Vertigo/dizziness

1.7

17.4

402

2496

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.3

17.4

281

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

17.4

796

5816

K02.1

ICD-10 Finland

Caries of dentine

1.3

17.4

1879

15886

L17

ICPC

Foot/toe symptom/complaint

1.4

17.4

883

6583

S22.3

ICD-10 Finland

Fracture of rib

2.0

17.3

231

1195

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.3

17.3

261

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

42.2

17.3

B81

ICPC

Anaemia vit B12/folate deficiency

2.3

17.2

160

707

JN4CD

NOMESCO Finland

Very extensive body CT

2.3

17.2

164

736

E66.9

ICD-10 Finland

Obesity, unspecified

2.7

17.2

120

457

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.3

17.1

274

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

17.1

204

1012

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.9

17.0

251

1349

R13

ICD-10 Finland

Dysphagia

1.9

16.9

241

1281

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

13.3

16.9

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

16.9

134

545

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

10.1

16.9

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

16.8

280

1571

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.0

16.8

106

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.8

16.8

119

C02EA02

ATC

2.1

16.8

185

886

N18

ICPC

Paralysis/weakness

3.4

16.8

246

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.1

16.7

189

917

UJD02

NOMESCO Finland

Gastroscopy

2.1

16.6

193

943

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.8

16.6

191

EBA30

NOMESCO Finland

Excision of root of tooth

2.1

16.6

195

959

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

16.6

303

1752

T89

ICPC

Diabetes insulin dependent

2.8

16.6

110

404

S72.0

ICD-10 Finland

Fracture of neck of femur

2.2

16.6

169

782

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

90.4

16.6

A07EC02

ATC

mesalazine; oral, rectal

2.1

16.5

197

976

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

11.6

16.5

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.1

16.5

293

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.4

16.5

141

599

N06AX12

ATC

bupropion; oral

2.1

16.4

180

858

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.6

16.4

208

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.9

16.4

173

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.7

16.4

198

J01FA06

ATC

roxithromycin; oral

1.3

16.4

1467

12026

I50.1

ICD-10 Finland

Left ventricular failure

2.1

16.3

179

854

L04AX01

ATC

azathioprine; systemic

2.3

16.3

157

708

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

16.2

1523

12565

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

16.2

142

610

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

16.2

176

838

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

15.4

16.2

A10BB12

ATC

glimepiride; oral

1.9

16.1

261

1450

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.3

16.1

243

K77

ICPC

Heart failure

3.0

16.1

321

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.9

16.0

172

R31

ICD-10 Finland

Unspecified haematuria

1.7

16.0

336

2028

B03XA02

ATC

darbepoetin alfa; parenteral

3.5

16.0

223

R03DA04

ATC

theophylline; systemic, rectal

2.0

16.0

215

1119

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

16.0

652

4648

D10

ICPC

Vomiting

2.2

15.9

163

757

ZZA00

NOMESCO Finland

Split skin graft

2.5

15.9

126

515

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.3

15.9

151

674

309

Kela drug reimbursment

Nalmefene and naltrexone

10.1

15.9

Z93.2

ICD-10 Finland

Ileostomy status

9.0

15.9

C09DA03

ATC

valsartan and diuretics; oral

2.1

15.8

185

908

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.6

15.8

117

460

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.6

15.8

200

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

6.4

15.7

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.9

15.7

320

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

15.7

274

1561

TK800

NOMESCO Finland

Hemodialysis

3.3

15.7

248

N06AA06

ATC

trimipramine; systemic

2.7

15.7

105

388

N03AF02

ATC

oxcarbazepine; oral

2.6

15.7

111

427

WX290

NOMESCO Finland

Other blockade of nerve

1.3

15.6

1345

10943

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.5

15.6

124

509

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.7

15.6

105

392

J45

ICD-10 Finland

Asthma

1.7

15.5

336

2049

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.2

15.5

251

D11

ICPC

Diarrhoea

1.7

15.4

347

2138

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

6.8

15.4

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.8

15.4

348

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.6

15.4

115

455

E260, I152

ICD-10 Finland

38.2

15.4

N06AX26

ATC

vortioxetine; oral

2.1

15.3

172

831

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

15.3

203

1052

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.8

15.2

100

368

P03

ICPC

Feeling depressed

1.8

15.2

246

1367

N06AX05

ATC

trazodone; oral

2.8

15.2

362

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3020779) Urea [Moles/volume] in Serum or Plasma

1003

2798

4.27

323.31

8.8

5.9

mmol/l

10.2

9.5

1.71

954

2652

(3024354) Oxygen [Partial pressure] in Venous blood

947

2596

4.30

311.71

5.8

2.8

kpa

4.6

4.5

0.35

905

2510

(3016038) Potassium [Moles/volume] in Urine

258

135

20.14

307.65

1.8

1.3

mmol/l

34.1

34.6

0.08

228

106

(3023368) Bacteria identified in Blood by Culture

2331

9884

3.65

307.65

6.4

3.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

579

357

18.32

307.65

1.7

1.3

pmol/l

384.7

271.9

4.09

402

285

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1204

3059

4.92

307.65

6.4

3.3

kpa

5.9

5.8

0.13

1159

2965

(3023183) Ammonium ion [Moles/volume] in Plasma

477

583

8.98

307.65

3.5

2.7

umol/l

35.6

35.4

0.04

415

497

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3126

17157

3.38

307.65

11.5

5.0

mmol/l

1.2

44.94

2923

15332

(3024561) Albumin [Mass/volume] in Serum or Plasma

3016

16171

3.34

307.65

7.9

4.2

g/l

33.3

35.4

67.10

2847

14832

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3383

19028

3.66

307.65

12.4

5.6

mmol/l

1.2

26.76

2882

15887

(3003181) Sodium [Moles/volume] in Urine

467

387

13.27

307.65

1.8

1.2

mmol/l

63.1

65.6

0.39

375

298

(3002032) Base excess in Venous blood by calculation

1209

3042

4.98

307.65

6.4

3.3

mmol/l

3.0

2.1

7.47

1030

2468

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1233

2878

5.43

307.65

2.6

2.2

nmol/l

384.2

371.1

0.87

1133

2616

(3014576) Chloride [Moles/volume] in Serum or Plasma

1417

4352

4.21

307.65

9.4

6.1

mmol/l

102.6

104.5

22.28

1397

4273

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2342

5508

7.38

307.65

5.3

3.0

mmol/l

0.8

29.23

2219

5090

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1562

4163

5.09

307.65

7.4

4.7

mmol/l

1.0

1.62

1465

3834

(3000991) Gas panel - Venous blood

998

2713

4.39

307.65

11.5

7.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

970

2532

4.55

307.65

2.1

1.6

—

(3011985) Renin [Units/volume] in Plasma

630

372

19.35

307.65

1.8

1.3

mu/l

58.6

50.7

0.29

537

332

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

686

1501

5.17

298.58

6.1

3.6

mmol/l

25.0

24.3

2.96

635

1326

(3014111) Lactate [Moles/volume] in Serum or Plasma

994

2922

4.03

296.29

9.6

6.0

mmol/l

1.5

1.3

3.07

943

2824

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3265

19456

3.14

294.39

10.0

5.8

umol/l

12.7

11.5

3.37

3120

18357

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1976

9260

2.93

272.34

2.9

2.2

mg/l

3.2

3.0

2.80

1716

7878

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1469

5875

3.17

268.37

2.4

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3439

21803

3.06

263.55

9.4

4.0

mmol/l

6.8

6.7

5.39

3327

20267

(3032080) INR in Blood by Coagulation assay

2689

15037

2.80

261.03

12.3

8.7

inr

1.3

0.45

812

4228

(3009343) pH of Capillary blood

774

2082

4.24

258.52

5.9

3.5

7.4

0.31

117

259

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2265

11654

2.79

257.92

4.3

2.4

u/l

57.4

58.1

0.28

2123

10644

(3022948) Iron [Moles/volume] in Serum or Plasma

1379

5435

3.16

256.87

3.1

2.2

umol/l

11.1

12.9

15.16

1267

4988

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1298

4948

3.23

255.80

3.1

2.2

g/l

2.2

2.3

5.98

1192

4528

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

779

2122

4.19

255.65

5.9

3.5

kpa

5.2

0.19

728

1946

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1013

3351

3.57

250.59

3.2

2.2

g/l

0.2

3.54

914

3138

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2155

10973

2.76

247.99

3.1

2.0

u/l

292.9

207.3

1.32

2048

10220

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

745

2014

4.20

246.58

5.9

3.5

mmol/l

2.7

2.1

3.35

600

1514

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1224

4605

3.23

245.51

3.1

2.2

21.1

22.3

1.94

1043

3912

(3003396) Base excess in Arterial blood by calculation

1109

3962

3.34

242.04

10.0

6.5

mmol/l

2.2

1.2

7.40

928

3055

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1103

3986

3.30

235.66

10.0

6.5

kpa

5.0

5.1

1.54

1053

3791

(3018418) pH of Serum or Plasma

2140

11089

2.68

234.55

6.2

3.4

7.4

2.95

489

2109

(3027801) Oxygen [Partial pressure] in Arterial blood

1101

3985

3.29

234.52

10.0

6.5

kpa

11.4

12.5

9.16

1050

3785

(3016502) Oxygen saturation in Arterial blood

997

3504

3.33

221.81

10.6

6.8

95.3

95.7

1.14

964

3376

(3026782) Osmolality of Urine

1562

7091

2.79

219.83

3.8

2.6

mosm/kgh2o

488.8

548.0

21.79

1382

5942

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

488

1028

5.17

219.82

1.5

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

706

2004

3.96

217.09

9.6

6.7

mmol/l

25.5

25.0

1.88

697

1986

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2467

14312

2.50

205.29

6.2

3.3

ng/l

78.5

84.9

0.05

1957

9986

(3004119) Hemoglobin [Mass/volume] in Venous blood

698

2049

3.82

203.93

5.5

2.8

g/l

124.3

129.0

5.66

680

1995

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2047

10966

2.52

201.65

3.9

2.8

ng/l

1784.1

1351.5

4.92

1809

9323

(3027945) Reticulocytes/100 erythrocytes in Blood

1042

3999

3.05

197.67

2.5

2.0

1.8

7.72

912

3526

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2059

11247

2.46

192.07

4.7

3.0

u/l

46.5

33.6

0.98

1936

10587

(3026008) Bacteria identified in Urine by Culture

2163

12113

2.44

190.46

4.6

3.1

—

(42870588) Differential panel, method unspecified - Blood

2186

12312

2.43

189.88

7.5

5.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

776

2578

3.40

186.87

4.7

3.1

ng/l

98.8

85.0

2.52

653

2162

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1008

3968

2.95

181.29

2.2

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1006

3959

2.95

181.00

2.3

1.7

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

885

3251

3.11

179.84

11.6

7.1

g/l

118.8

121.0

2.27

859

3129

(3019309) Folate [Moles/volume] in Red Blood Cells

1516

7378

2.54

179.26

2.1

1.7

nmol/l

1244.7

1183.9

1.37

1158

5476

(3006315) Basophils [#/volume] in Blood

2829

18204

2.36

176.41

7.8

5.5

e9/l

0.0

0.00

2498

15608

(3019069) Monocytes/100 leukocytes in Blood

2697

17007

2.34

176.31

8.5

6.0

8.6

8.7

0.74

2548

15748

(3001604) Monocytes [#/volume] in Blood

2816

18118

2.35

175.16

7.8

5.5

e9/l

0.6

15.84

2490

15532

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

991

3951

2.90

173.44

2.9

4.3

u/l

244.7

244.5

0.02

918

3735

(3006504) Eosinophils/100 leukocytes in Blood

2675

16898

2.32

172.89

8.1

5.8

2.5

2.9

13.39

2523

15567

(3013115) Eosinophils [#/volume] in Blood

2881

18817

2.34

171.51

8.2

5.7

e9/l

0.2

3.37

2566

16388

(1616796) Gas panel - Central venous blood

356

713

5.31

168.96

4.1

3.4

—

(3022096) Basophils/100 leukocytes in Blood

2607

16399

2.30

168.70

8.1

5.8

0.6

0.7

8.13

2452

15127

(3013650) Neutrophils [#/volume] in Blood by Automated count

3141

21402

2.36

167.55

12.8

8.6

e9/l

4.7

4.1

31.96

2804

18594

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1177

5219

2.67

167.14

2.6

1.9

30.0

29.7

0.77

1134

5045

(3002030) Lymphocytes/100 leukocytes in Blood

2718

17439

2.29

167.12

8.3

5.9

24.1

27.8

53.09

2552

16051

(3019198) Lymphocytes [#/volume] in Blood

2843

18651

2.29

164.76

8.0

5.6

e9/l

1.8

1.9

3.49

2528

16301

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

637

2018

3.49

164.27

1.8

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

815

3005

3.06

163.45

2.6

e9/l

73.0

68.1

2.97

623

2270

(3035637) Corticotropin [Mass/volume] in Plasma

252

373

7.08

162.79

1.6

1.5

—

(3018010) Neutrophils/100 leukocytes in Blood

2676

17177

2.27

162.73

7.9

5.6

60.9

57.3

40.16

2512

15889

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1414

6936

2.47

161.73

5.4

3.4

ng/l

233.7

514.0

0.99

1192

5470

(3027273) Bicarbonate [Moles/volume] in Venous blood

558

1646

3.71

160.24

6.3

2.9

mmol/l

26.3

25.5

3.82

537

1600

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

269

436

6.48

159.37

1.2

1.3

nmol/l

1.2

0.6

0.44

259

420

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

454

1163

4.21

159.02

2.4

2.1

ug/l

795.3

629.6

0.26

431

1093

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

549

1610

3.72

158.98

5.2

2.4

1.4

1.2

2.56

549

1600

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

270

442

6.41

158.39

1.2

1.3

nmol/l

0.4

0.3

0.14

(3002582) Erythrocytes [#/volume] in Urine

1957

11165

2.27

157.10

4.8

3.0

e6/l

121.7

99.1

0.19

1626

8443

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2423

15109

2.22

155.92

3.9

2.6

ug/l

164.3

128.1

6.59

2243

13767

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2486

15681

2.22

155.21

2.5

1.9

pmol/l

88.0

96.0

14.37

1478

7838

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

493

1384

3.86

151.90

2.4

1.9

ug/l

2.1

2.5

0.24

435

1210

(3022313) Gas panel - Capillary blood

522

1525

3.72

151.77

6.5

3.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3862

29422

2.63

151.74

13.2

7.0

u/l

88.6

78.5

25.57

3716

27404

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

532

1577

3.67

151.36

5.1

2.4

0.7

1.05

524

1502

(3021960) Folate [Moles/volume] in Serum or Plasma

1643

8825

2.31

151.10

1.9

1.5

nmol/l

19.3

21.0

4.00

1452

7422

(3031040) Bacteria [#/volume] in Urine by Automated count

3480

25366

2.37

149.77

7.3

4.5

e6/l

1873.4

2938.0

0.35

300

(3015377) Calcium [Moles/volume] in Serum or Plasma

2182

13209

2.20

149.24

4.4

3.3

mmol/l

2.3

2.4

7.58

1880

11339

(3042936) Bacteria identified in Isolate by Culture

1103

4989

2.57

148.37

2.7

1.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

360

812

4.71

148.23

4.4

2.8

mmol/l

25.3

25.4

0.17

317

696

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2452

15606

2.17

146.86

3.2

2.1

nmol/l

75.0

79.7

11.70

2235

13751

(3008295) Osmolality of Serum or Plasma

203

270

7.81

144.11

1.7

1.4

mosm/kgh2o

275.7

283.3

3.34

162

192

(3019060) Gas panel - Arterial blood

670

2364

3.13

143.95

6.7

4.5

—

(3018095) Leukocytes [#/volume] in Urine

2133

13093

2.14

137.52

5.6

3.4

e6/l

130.5

114.9

0.17

1673

9173

(3030467) Casts [#/volume] in Urine by Automated count

1798

10368

2.18

135.85

4.5

2.9

e6/l

0.6

0.4

1.64

1461

7776

(3024928) Oxygen saturation in Venous blood

303

637

5.01

135.57

3.5

2.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

859

3581

2.71

135.22

2.7

1.7

1.8

1.4

20.52

707

3150

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

238

402

6.18

135.13

1.2

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3500

26130

2.27

133.43

6.6

4.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

540

1755

3.34

132.54

11.9

8.2

mmol/l

25.0

24.4

2.47

505

1626

(3028626) Oxygen [Partial pressure] in Capillary blood

328

752

4.61

132.11

5.0

3.3

kpa

8.3

8.2

0.30

305

697

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

911

3967

2.60

131.00

4.1

2.6

umol/l

10.9

8.6

1.84

784

3422

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

493

1540

3.45

128.75

1.5

1.6

g/l

1.7

1.5

4.88

423

1305

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

139

132

10.82

127.83

1.8

1.6

nmol/l

10.1

7.9

0.21

119

103

(3000850) Epithelial cells [#/volume] in Urine

1442

7845

2.20

124.03

3.7

2.4

e6/l

7.2

5.7

2.57

1297

6786

(3033658) Prothrombin time (PT) actual/Normal

1599

9071

2.15

123.51

7.1

3.6

85.3

89.7

8.97

1565

8834

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

225

394

5.94

123.03

1.2

1.3

nmol/l

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

491

1573

3.36

123.01

7.1

3.4

50.3

48.5

0.82

485

1552

(3044640) Blood type and Crossmatch panel - Blood

1930

11783

2.07

122.34

3.5

2.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

585

2111

3.02

119.81

2.0

1.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

163

210

8.00

118.78

1.9

1.3

promille

1.5

1.3

0.67

129

163

(3027315) Oxygen [Partial pressure] in Blood

319

788

4.27

116.54

5.4

3.7

kpa

8.5

0.01

308

769

(3012501) Base excess in Blood by calculation

317

780

4.28

116.41

5.4

3.7

mmol/l

3.6

2.6

5.57

250

537

(3013290) Carbon dioxide [Partial pressure] in Blood

317

781

4.28

116.21

5.4

3.7

kpa

5.0

0.22

306

762

(3010421) pH of Blood

350

932

3.97

115.46

5.5

3.5

7.4

1.12

306

762

(36304419) Bacteria [Presence] in Urine

1703

10101

2.07

115.17

4.5

2.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

914

4219

2.44

114.73

2.3

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1420

7878

2.14

114.65

2.0

1.7

mg/l

1.4

1.3

0.78

1123

6007

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

436

1363

3.42

113.30

7.2

3.8

mmol/l

25.9

25.0

4.18

401

1251

(3021901) Oxygen saturation in Capillary blood

267

589

4.74

112.54

3.4

2.5

—

(40767503) Oxygen content in Capillary blood by calculation

299

729

4.31

111.05

3.4

2.2

15.7

16.2

0.96

164

356

(3000570) Elastase.pancreatic [Mass/mass] in Stool

368

1043

3.74

110.96

1.5

1.4

ug/g

234.9

277.8

3.69

247

616

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

761

3274

2.58

110.76

3.8

2.3

u/l

32.4

53.2

0.80

652

2787

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2520

17370

1.95

108.95

5.6

3.9

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

586

2231

2.85

108.38

10.6

6.7

mmol/l

25.5

24.7

2.69

558

2077

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

101

13.55

107.57

1.3

1.2

pmol/l

507.1

279.1

2.24

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3134

23326

2.00

107.40

5.8

2.9

u/l

83.2

47.1

28.63

2922

21408

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

500

1754

3.07

107.14

14.0

9.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1013

5027

2.29

106.98

25.9

25.6

inr

1.4

0.54

133

714

(3020630) Protein [Mass/volume] in Serum or Plasma

711

3010

2.60

106.73

2.6

2.4

g/l

65.0

66.5

4.44

638

2681

(3028026) IgM [Mass/volume] in Serum or Plasma

507

1923

2.83

93.88

1.9

1.8

g/l

1.3

1.4

0.61

454

1744

(3005719) IgG [Mass/volume] in Serum or Plasma

600

2491

2.61

93.03

2.6

2.7

g/l

10.4

10.6

0.20

539

2271

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1063

5680

2.12

91.72

4.1

2.8

e6/l

4.5

2.8

3.29

636

3028

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

408

1401

3.09

90.26

7.0

4.9

1.8

1.6

1.72

385

1309

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

695

3163

2.40

88.26

3.9

2.7

ng/l

268.5

192.6

2.46

635

2866

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1480

9044

1.92

86.70

3.5

2.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1260

7292

1.99

86.66

4.2

3.0

mmol/l

2.5

1.75

1088

6370

(3009508) Creatinine [Moles/volume] in Urine

1730

11206

1.85

83.92

3.6

3.0

mmol/l

6.6

7.3

8.08

1441

9278

(3036603) Volume of Urine

129

191

6.91

83.02

1.8

1.6

2110.1

1786.5

0.80

(3007930) Methemoglobin/Hemoglobin.total in Blood

394

1392

2.99

82.74

7.3

4.9

0.9

1.21

372

1298

(37021550) Renin [Units/volume] in Plasma --upright

12.31

80.53

1.4

1.3

mu/l

125.5

45.1

1.36

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

783

3902

2.20

79.67

5.7

3.2

—

(3025941) Bacteria identified in Stool by Culture

479

1925

2.65

78.77

1.5

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

337

1120

3.16

78.60

4.1

2.8

u/ml

0.3

0.13

206

620

(3047181) Lactate [Moles/volume] in Blood

319

1027

3.26

78.44

8.2

5.9

mmol/l

1.5

1.3

1.67

282

903

(40758558) Short blood count panel - Blood

1493

9403

1.85

78.01

9.8

6.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1709

11250

1.81

77.07

4.3

3.7

mg/mmol

26.6

6.7

1.35

1138

6768

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

274

815

3.51

76.39

6.1

3.6

mg/l

1.7

1.5

3.77

252

739

(3026493) Urate [Moles/volume] in Serum or Plasma

1477

9324

1.85

76.26

3.4

2.4

umol/l

4055.5

5071.7

0.41

1269

7944

(3004588) Protein electrophoresis panel - Serum or Plasma

563

2488

2.43

75.70

2.3

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

800

4118

2.13

74.56

4.2

3.9

ug/l

19.8

25.1

0.25

684

3320

(3035350) Ketones [Presence] in Urine by Test strip

2483

18402

1.73

72.50

5.5

3.7

estimate

0.0

0.50

569

3388

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1082

6284

1.93

71.72

3.7

2.6

e6/l

1.7

0.01

648

3603

(3021601) Nitrite [Presence] in Urine by Test strip

2483

18473

1.72

70.85

7.2

4.9

estimate

0.0

0.80

576

3415

(3009261) Glucose [Presence] in Urine by Test strip

2506

18711

1.71

70.40

5.5

3.7

estimate

0.0

1.57

569

3363

(3009445) Proteinase 3 Ab [Units/volume] in Serum

380

1443

2.77

69.58

1.4

1.5

u/ml

4.1

21.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

314

1075

3.06

69.46

2.7

3.0

mg/l

36.9

46.5

0.79

248

871

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

307

1038

3.09

69.39

2.7

3.0

ratio

1.4

2.0

1.08

(3034860) Kappa light chains.free [Mass/volume] in Serum

314

1077

3.05

69.23

2.7

3.0

mg/l

67.9

56.0

0.29

250

867

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

652

3191

2.21

68.68

5.7

3.2

mmol/l

1.2

6.68

610

2722

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

36.15

68.60

1.1

1.3

pmol/l

175.7

305.6

—

(3021589) Normoblasts [#/volume] in Blood

2249

16415

1.70

67.79

16.8

8.9

e9/l

0.0

0.49

1902

13424

(3012516) Albumin [Mass/volume] in Urine

1603

10697

1.75

66.75

3.4

3.0

mg/l

419.1

334.3

0.32

1091

6477

(3015736) pH of Urine

2007

14275

1.70

66.09

4.8

3.5

—

5.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1098

6568

1.87

65.72

1.6

1.4

g/l

2.9

2.4

5.39

715

3846

(40768797) Stomach Pathology biopsy report

904

5089

1.96

64.99

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1322

8402

1.79

64.79

1.9

1.7

pmol/l

17755811.7

33251203.8

0.70

1087

6863

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

179

445

4.14

64.52

7.7

6.6

mg/l

12.8

11.6

2.67

166

406

(3013512) EKG study

1677

11435

1.72

64.00

5.7

3.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

262

847

3.21

63.82

1.7

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

263

860

3.18

62.84

1.2

titre

84.7

95.4

0.19

(3006184) Hemoglobin [Mass/volume] in Capillary blood

244

764

3.31

62.62

2.7

2.1

g/l

125.6

128.3

0.87

204

528

(3013707) Erythrocyte sedimentation rate by Westergren method

3407

28139

1.73

61.74

5.6

4.0

mm/h

18.1

12.6

51.76

3169

25777

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

289

1010

2.98

61.55

2.0

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

340

1308

2.72

60.54

6.3

3.8

mmol/l

1.6

1.3

2.25

334

1298

(3017143) Hepatitis C virus Ab [Presence] in Serum

652

3342

2.10

60.54

1.8

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

613

3080

2.14

59.93

4.7

4.1

0.9

0.11

249

857

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

634

3234

2.11

59.57

3.4

2.3

ug/l

5.4

6.8

1.24

520

2770

(3020891) Body temperature

374

1527

2.57

59.06

9.7

4.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

358

1445

2.60

57.86

2.3

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

380

1586

2.52

57.27

2.4

1.9

—

(3037522) Nuclear Ab [Titer] in Serum

821

4662

1.92

56.79

1.4

1.3

titre

403.3

547.4

2.24

159

1009

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3458

28957

1.70

56.42

5.0

3.9

pmol/l

15.1

14.9

7.69

3180

25978

(44816559) Phosphatidylethanol [Mass/volume] in Blood

186

523

3.66

56.34

2.0

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

113

7.37

56.30

2.7

2.3

umol/l

125.1

153.0

0.26

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

235

769

3.16

56.03

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

235

769

3.16

56.03

1.4

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

239

794

3.12

55.54

1.6

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

247

837

3.06

55.48

1.5

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

239

795

3.11

55.42

2.6

3.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

247

839

3.05

55.24

1.8

1.6

—

(3034770) Mitochondria Ab [Titer] in Serum

250

860

3.01

54.69

1.2

titre

2320.0

977.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

579

2945

2.10

54.55

4.7

4.1

0.1

0.2

0.63

228

795

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4232

37857

2.03

52.66

34.8

13.1

mg/l

26.3

24.1

4.16

3855

29728

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

305

1193

2.66

52.44

2.6

2.7

—

(3028707) Methadone [Presence] in Urine by Screen method

140

341

4.20

51.85

3.0

2.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

432

2000

2.28

51.43

2.9

3.0

pmol/l

4.2

4.5

5.77

381

1749

(3039000) Anion gap in Blood

219

738

3.06

49.63

9.8

6.8

mmol/l

11.6

11.1

0.84

200

655

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

197

624

3.25

49.55

5.5

5.0

iu/ml

1412.2

3215.4

0.27

(3018572) Chloride [Moles/volume] in Blood

219

739

3.06

49.51

9.8

6.8

mmol/l

102.4

105.3

7.13

200

656

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

287

1125

2.65

49.09

1.6

titre

219.4

257.4

0.08

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1172

7691

1.69

48.97

1.4

1.3

u/ml

1.2

1.8

1.23

279

2001

(46235355) HIV 1 and 2 tests - Meaningful Use set

811

4790

1.83

48.94

1.8

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

314

1309

2.50

47.27

3.5

3.4

u/ml

1235.1

1941.4

0.28

268

1103

(3012565) Volume of 24 hour Urine

143

5.96

47.20

1.7

2.4

1967.9

1878.2

0.28

126

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

252

945

2.76

46.99

3.2

2.5

g/l

3.6

3.5

0.46

240

894

(3009466) Valproate [Moles/volume] in Serum or Plasma

152

424

3.67

46.59

4.8

5.0

umol/l

342.3

357.6

0.61

129

369

(3030981) Hyaline casts [#/volume] in Urine by Automated count

383

1762

2.28

46.15

4.1

2.4

e6/l

0.4

0.3

0.95

372

1718

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

165

489

3.46

46.15

1.8

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

131

333

4.02

45.82

3.1

2.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

536

2820

2.01

45.65

4.4

4.0

0.6

0.27

184

615

(3048689) Calprotectin [Mass/mass] in Stool

718

4180

1.84

45.09

2.4

2.2

ug/g

212.8

136.6

3.88

575

3219

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

193

643

3.09

44.60

1.8

1.7

—

(3025159) Blasts/100 leukocytes in Blood

523

2771

2.00

43.58

4.9

4.1

0.0

0.4

1.47

195

665

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

702

4117

1.83

42.89

1.8

1.5

—

(3037121) Protein [Mass/volume] in Urine

287

1231

2.42

40.53

3.8

2.8

g/l

0.4

0.3

1.28

151

450

(40760892) CBC W Ordered Manual Differential panel - Blood

1158

7911

1.61

40.06

6.3

4.3

—

(3019225) pH of Specimen

684

4064

1.80

39.81

7.6

3.7

—

(3037756) Immunofixation for Serum or Plasma

202

741

2.80

39.25

1.5

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

256

1058

2.50

39.18

1.5

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

270

1145

2.44

39.09

7.2

4.0

mmol/l

3.6

3.9

6.16

252

1097

(42529406) Shigella sp [Presence] in Stool by Culture

256

1062

2.49

38.86

1.5

1.2

—

(3011648) Oxygen content in Venous blood

231

4.36

38.82

3.7

2.6

10.2

11.0

0.95

231

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1873

14322

1.51

38.77

6.0

4.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

100

239

4.25

38.01

1.3

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

251

1050

2.47

37.42

1.5

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3885

34718

1.64

37.24

6.3

4.6

mu/l

2.0

0.45

3604

31315

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

112

5.96

37.24

3.3

2.9

—

(3011288) Drugs identified in Urine by Screen method

160

532

3.08

37.11

4.3

2.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

231

4.27

37.05

1.3

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1344

9654

1.55

36.89

5.4

3.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

163

551

3.03

36.74

1.3

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

302

1382

2.27

36.71

2.7

2.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

148

473

3.20

36.70

1.6

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

251

1061

2.44

36.58

4.9

3.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

302

1385

2.26

36.52

2.7

2.1

g/l

7.5

7.4

0.38

208

1023

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

175

618

2.90

36.49

3.1

2.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

146

465

3.21

36.41

1.7

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

301

1383

2.26

36.23

2.7

2.1

g/l

3.9

3.8

0.40

204

972

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

148

479

3.16

35.94

1.6

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

285

1297

2.27

35.09

2.7

2.1

g/l

10.6

10.4

0.19

231

1069

(1001926) Buprenorphine [Presence] in Urine by Screen method

169

599

2.89

35.01

2.8

1.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

143

464

3.15

34.58

1.6

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

143

466

3.13

34.33

1.6

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

234

987

2.44

34.25

3.2

2.2

88.3

91.8

1.18

225

924

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

220

903

2.51

34.15

2.8

2.3

215.8

191.3

3.30

213

858

(3025468) Yersinia sp identified in Specimen by Organism specific culture

142

464

3.12

33.94

1.6

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

231

976

2.44

33.69

1.5

1.6

g/l

0.2

0.25

215

927

(3019550) Sodium [Moles/volume] in Serum or Plasma

4290

39608

1.81

33.55

44.6

14.9

mmol/l

138.9

139.8

62.29

4229

38480

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

172

630

2.79

33.53

1.8

1.4

—

(3016879) Cocaine [Presence] in Urine

186

715

2.67

33.02

3.0

1.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

178

671

2.72

32.84

1.7

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

235

1014

2.39

32.71

1.5

1.6

g/l

1.2

0.16

220

966

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

156

550

2.90

32.64

1.8

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

228

4.05

32.52

1.1

1.0

mg/l

282.5

293.5

0.53

204

(3027456) Digoxin [Moles/volume] in Serum or Plasma

201

810

2.55

32.43

3.6

3.2

nmol/l

0.9

0.8

0.29

154

621

(3016650) Hepatitis A virus Ab [Presence] in Serum

143

482

3.03

32.41

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4292

39723

1.79

32.03

45.3

15.0

mmol/l

3.8

4.0

267.76

4228

38512

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

293

1401

2.16

31.92

2.0

1.8

u/l

39.3

39.8

0.15

252

1229

(3036489) Thrombin time

267

1231

2.24

31.84

2.7

1.9

22.3

21.2

1.05

246

1066

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

143

489

2.98

31.61

3.7

2.8

u/ml

675.8

1436.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

277

1301

2.20

31.56

2.8

2.1

g/l

3.2

3.1

0.66

206

1000

(3024980) IgG subclass 4 [Mass/volume] in Serum

148

517

2.92

31.49

1.4

1.6

g/l

0.8

0.06

112

384

(3023419) Bacteria identified in Sputum by Culture

133

439

3.09

31.27

2.4

2.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

155

561

2.82

30.91

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

141

486

2.96

30.74

1.8

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

193

785

2.52

30.54

3.0

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

1378

10274

1.48

30.50

6.3

4.1

estimate

0.0

0.06

552

3328

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

124

400

3.16

30.31

1.7

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

145

513

2.88

30.16

1.7

1.4

—

(3000494) Fungus identified in Specimen by Culture

666

4224

1.67

30.09

1.7

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

102

295

3.51

29.69

1.8

1.6

—

(4198724)

6.13

29.68

2.5

1.9

—

(3044927) Protein electrophoresis panel - Urine

115

361

3.24

29.42

1.3

1.1

—

(3028300) Cannabinoids [Presence] in Urine

192

793

2.48

29.42

3.0

1.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

114

358

3.24

29.15

1.2

u/l

65.5

61.3

0.17

228

(3004809) Band form neutrophils/100 leukocytes in Blood

159

602

2.70

29.11

3.3

3.8

1.4

1.6

0.25

134

461

(3027008) Opiates [Presence] in Urine

190

788

2.47

28.85

2.9

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

120

393

3.11

28.61

3.4

4.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

134

470

2.90

28.33

1.4

g/l

31.2

32.6

0.53

123

425

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

183

753

2.49

28.27

1.5

—

(3044889) 12 lead EKG panel

3080

26793

1.42

28.10

5.3

3.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

115

372

3.14

28.01

1.7

1.8

—

(4062490)

105

324

3.29

27.64

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

238

3.70

27.53

1.1

u/ml

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

195

840

2.38

27.25

3.2

u/ml

703.8

831.0

0.10

178

764

(3001186) Copper [Moles/volume] in Serum or Plasma

6.67

27.18

1.8

1.1

umol/l

17.4

16.8

0.16

(40761536) Microorganisms panel - Urine sediment

530

3246

1.71

27.14

6.5

3.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

154

596

2.64

27.01

1.6

1.8

nmol/l

1.0

0.8

1.76

125

498

(3011397) Hemoglobin [Presence] in Urine by Test strip

1201

8888

1.47

27.01

5.0

3.8

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

41.48

26.75

1.2

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

104

329

3.21

26.30

1.3

g/l

2.7

3.0

0.67

224

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

220

1014

2.23

26.25

2.9

2.1

g/l

0.0

0.23

199

921

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

137

507

2.75

26.23

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

116

393

3.00

26.11

1.9

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

170

702

2.47

26.08

1.6

1.3

mmol/l

3.9

3.7

0.81

155

653

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

103

326

3.21

26.03

1.6

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

103

326

3.21

26.03

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

103

326

3.21

26.03

1.6

1.8

—

(3027944) Amphetamines [Presence] in Urine

182

776

2.40

26.03

2.7

1.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

257

3.51

26.01

1.2

—

(3017704) Immunofixation for Urine

158

4.29

26.00

1.3

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2510

21250

1.38

25.77

3.2

2.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

103

329

3.18

25.64

1.3

g/l

0.5

0.4

0.52

222

(3027135) IgG subclass 1 [Mass/volume] in Serum

103

329

3.18

25.64

1.3

g/l

7.2

6.7

0.51

224

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

177

4.06

25.61

1.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

177

4.06

25.61

1.3

1.5

—

(3042631) Mycobacterium sp identified in Specimen

133

497

2.72

25.01

2.6

3.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

241

1176

2.11

24.89

2.8

2.2

g/l

0.6

1.1

1.47

203

995

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

152

609

2.55

24.86

1.7

1.3

—

(44806118)

113

388

2.96

24.86

1.6

1.4

—

(44790048)

113

388

2.96

24.86

1.6

1.4

—

(44790047)

113

388

2.96

24.86

1.6

1.4

—

(44790049)

113

388

2.96

24.86

1.6

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

184

807

2.33

24.70

1.8

1.3

mg/l

568.2

541.1

0.17

176

759

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

286

3.30

24.65

1.9

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

149

4.27

24.37

1.4

1.2

nmol/l

143.8

133.5

0.65

149

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

119

426

2.84

24.28

1.1

g/l

1.7

1.5

2.31

101

382

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

226

1095

2.12

23.78

2.8

2.0

g/l

35.8

37.6

3.82

188

911

(3023199) Leukocytes [#/volume] in Pleural fluid

115

409

2.86

23.75

1.4

e6/l

9570.4

2514.7

0.45

298

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

205

959

2.19

23.59

3.0

2.1

g/l

0.0

0.50

184

869

(3040151) Glucose [Moles/volume] in Capillary blood

107

369

2.94

23.38

6.8

21.9

mmol/l

6.9

7.1

0.28

299

(40768806) Pleura Pathology biopsy report

107

371

2.93

23.15

1.5

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

110

4.77

23.10

2.8

1.8

e6/l

763.6

749.3

0.01

(3020717) Zinc [Moles/volume] in Serum or Plasma

160

4.04

23.02

3.4

1.3

umol/l

17.6

23.8

1.01

150

(3044290) Cell count panel - Cerebral spinal fluid

154

644

2.44

23.02

2.0

1.4

—

(3042733) HLA Ab [Presence] in Serum

5.74

22.39

4.6

4.9

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

199

941

2.16

22.30

3.0

2.1

g/l

0.0

0.00

184

867

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

191

889

2.20

22.27

1.9

mg/l

12.3

11.3

0.68

174

817

(3033923) Metanephrine [Moles/time] in 24 hour Urine

5.95

22.12

1.1

1.2

umol/24h

0.8

0.7

0.65

(3019977) pH of Arterial blood

174

3.83

22.08

3.2

2.5

7.4

0.35

(3022145) Colonoscopy Study observation

616

4116

1.57

22.05

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

300

1649

1.87

22.04

1.5

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

136

550

2.52

21.85

1.8

1.3

u/ml

106.2

120.8

0.83

118

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

148

623

2.42

21.82

1.7

1.3

—

18.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

4.93

21.77

2.9

1.6

e6/l

9756.6

30143.6

0.50

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

166

736

2.30

21.76

3.7

3.6

59.5

57.9

0.70

166

736

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

137

562

2.48

21.36

1.6

1.2

u/ml

263.5

272.9

0.13

328

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

144

605

2.42

21.32

1.5

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

188

887

2.17

21.19

1.3

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

6.01

21.19

3.1

2.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

159

701

2.31

21.12

1.7

1.4

e6/l

80.1

19.3

0.40

132

550

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

159

703

2.31

20.98

1.7

1.5

e6/l

308.6

1319.5

1.54

137

577

(3012441) Differential panel - Pleural fluid

350

2.87

20.72

1.6

1.5

—

(3011412) CD3 cells [#/volume] in Blood

318

2.96

20.67

1.7

2.4

e9/l

1.2

1.1

0.53

194

(40761535) Cells panel - Urine sediment

518

3376

1.60

20.56

5.2

3.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

185

878

2.15

20.55

1.5

1.2

—

(3019150) Specific gravity of Urine by Refractometry

1086

8234

1.41

20.53

5.9

4.2

kg/l

1.0

1.31

202

1220

(4035726)

529

3474

1.59

20.32

1.5

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

216

1092

2.02

20.30

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

364

2174

1.73

20.25

1.5

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

102

374

2.76

19.96

1.4

e6/l

85905.3

60638.9

0.27

219

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

137

4.05

19.92

1.3

—

(3014271) Vancomycin [Susceptibility]

188

3.55

19.77

3.3

3.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

256

1390

1.89

19.54

1.2

u/ml

0.2

1.4

2.84

135

(3017315) Amylase [Enzymatic activity/volume] in Urine

181

3.57

19.38

1.6

1.2

u/l

363.2

268.5

0.24

171

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

188

3.49

19.03

1.2

1.1

u/l

27.2

22.7

0.30

154

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

240

1290

1.91

18.89

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

175

842

2.12

18.79

1.4

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

130

4.03

18.76

1.7

4.1

mg/l

71.3

65.6

0.22

(40768446) Kidney Pathology biopsy report

4.57

18.65

2.0

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

10.04

18.48

1.1

1.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

102

4.44

18.43

42.2

31.7

ug/l

7.2

7.4

0.19

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

169

3.58

18.30

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

234

3.15

18.17

2.0

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

199

3.35

18.14

1.3

1.1

u/l

93.9

89.9

0.12

168

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

214

3.26

18.13

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

4.60

17.95

2.9

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

211

3.25

17.86

2.1

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

100

385

2.63

17.84

3.2

4.1

65.3

56.0

3.06

243

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

232

3.14

17.77

1.8

2.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

173

848

2.08

17.71

1.9

1.6

mu/l

367.9

299.3

1.31

160

771

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.79

17.50

4.2

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.79

17.50

4.2

1.9

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

225

3.14

17.36

1.5

u/l

10.3

6.8

0.82

(3003694) ABO and Rh group [Type] in Blood

1229

9732

1.35

17.35

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

3374

30736

1.33

17.34

38.5

15.9

14.4

13.7

85.91

3326

29955

(3033799) Differential panel - Peritoneal fluid

4.37

17.29

2.3

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

157

3.60

17.21

1.9

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

211

3.21

17.19

2.1

1.6

—

(3042517) Benzodiazepines panel - Urine

11.29

17.09

1.6

1.9

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

238

3.06

17.04

1.2

1.3

u/l

17.0

11.9

0.38

217

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

204

3.22

16.78

1.7

2.8

e9/l

0.2

0.01

178

(3009542) Hematocrit [Volume Fraction] of Blood

3657

33769

1.35

16.77

33.1

14.3

37.1

39.3

28.59

2180

23061

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.66

16.55

1.2

—

(40761511) CBC panel - Blood by Automated count

4166

39348

1.46

16.43

31.5

12.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

332

2046

1.67

16.42

1.4

1.3

u/ml

280.8

215.1

0.29

312

1888

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

167

3.44

16.41

2.6

2.4

—

(3000330) Specific gravity of Urine by Test strip

313

1902

1.69

16.32

5.1

3.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

160

786

2.07

16.31

1.7

iu/l

3.7

4.1

0.28

259

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

173

3.38

16.25

2.9

3.0

—

(21494755) Public health laboratory ask at order entry panel

132

2688

0.48

16.13

1.3

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

146

696

2.13

16.10

1.5

1.4

u/l

12.0

0.00

117

570

(3026692) Albumin [Mass/volume] in Peritoneal fluid

4.65

16.08

1.9

1.3

g/l

12.5

14.0

0.37

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3763

34966

1.36

16.07

7.3

5.4

mmol/mol

40.8

39.5

10.44

3461

31807

(3004451) EKG impression Narrative

146

3.59

15.97

1.4

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

180

3.31

15.96

1.5

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

180

3.31

15.96

1.5

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

180

3.31

15.96

1.5

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

180

3.31

15.96

1.5

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

142

2796

0.49

15.72

1.7

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

162

3.42

15.72

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

213

3.08

15.64

1.7

2.7

e6/l

524.3

524.1

0.00

180

(3033705) Calcium.ionized [Moles/volume] in Venous blood

106

449

2.39

15.51

3.3

2.1

—

(3016018) Differential panel - Cerebral spinal fluid

325

2.64

15.42

2.3

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

327

2.63

15.24

1.2

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

116

516

2.28

15.19

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

266

2.81

15.12

1.6

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

247

2.86

14.81

1.7

2.1

11.5

14.3

1.03

106

(36660697) Celiac disease serology panel - Serum

414

2760

1.55

14.76

1.2

—

(3004775) Volume in Urine collected for unspecified duration

260

2.80

14.60

2.1

690.3

632.9

0.53

166

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

448

3052

1.52

14.45

4.3

2.5

ml/min/173m2

58.1

65.3

2.85

214

1186

(3045788) Cell count panel - Pleural fluid

321

2.58

14.22

1.5

—

(3017732) Neutrophils [#/volume] in Blood

386

2557

1.55

14.15

4.0

2.9

e9/l

4.6

4.1

2.35

261

1927

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

151

766

2.00

14.14

2.8

2.0

u/l

5002.4

3308.8

0.30

301

(3044242) Glucose [Moles/volume] in Arterial blood

160

3.27

13.92

1.7

2.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

119

559

2.16

13.68

1.2

—

(3017569) Oxygen content in Arterial blood

167

3.20

13.66

1.7

2.5

—

(3035880) pH of Pleural fluid

183

3.08

13.58

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

6.80

13.57

1.1

1.2

umol/24h

2.0

1.9

0.12

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

189

1048

1.84

13.57

1.7

1.6

iu/ml

0.5

8.4

0.71

223

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3814

35753

1.33

13.56

31.7

12.3

ml/min/173m2

77.2

78.4

2.57

3357

29381

(3010503) CD19 cells [#/volume] in Blood

210

2.93

13.52

1.6

2.5

e9/l

1.2

0.3

0.39

204

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.88

13.51

1.5

2.2

umol/l

20.2

18.0

0.39

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

4.00

13.33

1.5

ug/l

0.3

0.4

0.60

(21494890) Protein electrophoresis panel - 24 hour Urine

338

2.48

13.29

2.0

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

152

791

1.95

13.26

2.5

2.2

ug/min

144.5

87.9

0.85

454

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3928

37012

1.34

13.25

5.5

4.5

mmol/l

6.2

5.9

17.61

3551

33175

(3006922) Hepatitis E virus Ab [Presence] in Serum

214

2.87

13.08

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4235

40419

1.42

12.94

18.5

9.9

u/l

26.0

25.2

1.21

4131

38632

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

256

2.68

12.78

1.2

titre

88.6

146.7

—

(3016750) Collection duration of Urine

190

2.97

12.76

2.0

min

512.5

486.6

1.34

134

(3027923) C peptide [Moles/volume] in Serum or Plasma

169

3.10

12.75

1.5

1.3

nmol/l

1.3

1.2

0.47

133

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

269

2.63

12.64

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

177

984

1.83

12.62

5.6

4.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1862

0.45

12.46

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

126

3.43

12.45

32.5

24.7

ug/l

123.8

118.4

0.19

106

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

193

1107

1.77

12.41

1.5

1.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

117

3.53

12.36

2.6

2.2

—

(3023410) Appearance of Cerebral spinal fluid

302

2.51

12.32

2.2

1.6

—

(3000012) Reticulocyte production index

189

2.93

12.26

1.7

1.6

—

(3024932) HLA-DR beta [Type]

3.97

12.16

1.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

154

3.14

12.05

1.5

2.3

—

(3028433) Virus identified in Specimen by Culture

129

3.35

12.02

1.3

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

289

2.51

11.92

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

101

3.68

11.91

1.1

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

302

2.47

11.84

2.5

2.4

—

(3024471) HLA-A [Type]

3.88

11.80

1.1

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

5.13

11.72

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

189

2.88

11.67

1.3

1.2

—

(3051651) Icteric interference index of Serum or Plasma

200

2.82

11.66

5.2

2.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

152

3.11

11.65

1.4

2.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

152

3.11

11.65

1.4

2.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

184

2.90

11.62

1.2

1.1

u/l

35.8

29.4

0.38

139

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

168

3.00

11.61

4.3

4.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

264

2.56

11.54

1.7

2.3

44.2

39.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.74

11.54

3.2

1.8

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

218

2.73

11.54

1.6

2.7

e6/l

828.3

638.8

0.88

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

343

2.36

11.50

1.2

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

362

2.32

11.48

1.2

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.70

11.46

2.3

2.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.86

11.35

2.2

1.4

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

10.02

11.33

1.0

1.2

u/field

1.5

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

316

2104

1.54

11.33

2.6

2.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.13

11.31

1.6

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.55

11.16

2.3

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

318

2.38

11.07

1.3

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

184

2.85

11.04

1.2

1.1

u/l

94.5

92.1

0.06

140

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

3.77

11.00

1.3

1.4

pmol/l

14.6

15.4

0.38

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

218

2.68

10.99

1.5

1.2

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

7.29

10.98

1.8

1.6

23.0

15.8

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

122

3.30

10.92

2.8

2.1

umol/l

61.2

57.5

0.22

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

221

2.64

10.71

1.5

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

375

2.23

10.60

5.0

2.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.78

10.52

1.7

1.8

umol/l

57.2

45.5

0.48

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

4.17

10.34

1.9

2.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

792

6289

1.31

10.29

1.3

iu/ml

43.2

35.2

0.62

227

1960

(40757494) Bilirubin.total [Moles/volume] in Blood

215

2.62

10.21

3.6

2.4

umol/l

16.7

24.4

0.42

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

349

2.26

10.21

1.2

1.1

—

3.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

481

2.06

10.16

1.1

iu/ml

21.4

1189.1

0.53

112

(3006270) Folate [Moles/volume] in Blood

350

2.25

10.14

1.1

nmol/l

362.3

366.6

0.06

297

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

7.16

10.13

1.8

1.0

mg/l

54.9

38.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

319

2.31

10.10

1.2

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

194

2.70

10.03

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

195

2.68

9.93

1.1

1.0

—

(40768441) Liver Pathology biopsy report

236

2.52

9.91

1.8

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

9.25

9.87

2.7

3.8

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

16.72

9.86

1.1

mmol/l

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

6.42

9.80

2.1

1.8

54.3

57.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.62

9.79

1.2

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

475

2.04

9.75

1.2

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

310

2.28

9.41

2.2

2.1

umol/l

11.7

7.3

1.04

224

(3032057) Clostridioides difficile [Presence] in Stool

3.87

9.39

2.0

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

158

933

1.72

9.27

1.6

e6/l

12626.2

11724.7

0.14

109

690

(3022621) pH of Urine by Test strip

354

2515

1.44

9.22

4.0

3.1

—

(3045716) Anion gap in Serum or Plasma

169

2.74

9.17

2.2

2.4

mmol/l

8.4

9.3

1.07

131

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

235

2.44

9.01

1.3

u/ml

0.5

0.8

0.29

110

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

149

2.83

8.94

1.4

1.3

78.8

61.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.46

8.90

1.4

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

4.67

8.81

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

191

2.58

8.72

1.2

1.6

u/l

8.0

5.6

0.75

159

(3021788) Differential panel - Synovial fluid

124

696

1.80

8.69

1.7

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

102

539

1.91

8.64

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.02

8.61

1.2

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

5.02

8.61

3.9

5.6

ug/min

78.2

44.5

0.73

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.56

8.58

1.5

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.35

8.47

1.6

1.4

nmol/l

138.1

118.7

0.27

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

263

2.30

8.31

1.2

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

232

2.39

8.31

2.5

1.7

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

129

2.88

8.15

2.0

1.5

iu/ml

2178150.8

1635592.9

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

299

2.19

8.04

1.4

1.3

nmol/l

1.6

1.5

0.24

265

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

293

2.20

8.01

1.1

1.6

u/ml

15.9

22.4

1.11

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.87

7.99

1.0

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

212

1408

1.53

7.77

1.1

u/ml

0.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

168

1058

1.61

7.75

1.6

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

239

1630

1.49

7.72

1.2

1.1

titre

107.9

180.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

468

1.92

7.70

1.9

1.6

66.1

58.2

1.21

294

(21494814) CD8 cells/100 lymphocytes in Specimen

139

2.75

7.69

1.5

1.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

406

1.99

7.67

1.9

1.7

—

3.9

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.01

7.65

2.4

2.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

112

2.96

7.64

1.4

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.81

7.51

1.5

1.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

102

566

1.82

7.48

1.3

u/l

26.6

42.3

1.33

488

(4010399)

365

2706

1.38

7.47

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.13

7.39

1.2

1.3

ug/l

110.3

466.6

0.60

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

109

2.95

7.37

3.2

2.6

umol/l

30.6

29.4

0.14

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

3.35

7.37

1.2

1.4

18.0

25.7

0.73

(40768804) Tissue Pathology biopsy report

1760

15728

1.19

7.33

2.4

2.1

—

(3049717) Cytology report of Urine Cyto stain

209

1402

1.51

7.33

2.4

2.6

—

(3045414) Leukocytes [Presence] in Urine

246

1706

1.47

7.32

2.5

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

491

1.87

7.30

1.4

1.2

u/ml

6.9

3.6

0.76

203

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.04

7.30

1.6

3.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.40

7.24

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.30

7.23

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

241

2.25

7.22

1.8

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

144

2.65

7.21

1.4

1.2

—

(3016228) CD19 cells/100 cells in Blood

144

2.65

7.21

1.5

1.9

10.9

9.0

0.24

139

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

116

2.86

7.20

1.6

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

133

2.72

7.17

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

294

2.12

7.15

1.1

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

539

1.82

7.10

1.1

—

(3047189) Immunofixation for 24 hour Urine

157

2.56

7.08

1.6

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.39

6.96

1.4

1.3

g/l

25.7

29.3

0.36

(3020491) Glucose [Moles/volume] in Blood

260

2.17

6.83

1.5

1.8

mmol/l

7.7

6.6

1.00

166

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

4.10

6.80

1.7

2.1

mmol/l

1.4

1.8

0.31

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

223

2.26

6.72

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.01

6.70

10.9

8.7

mmol/l

5.0

6.2

0.86

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

5.73

6.58

3.3

3.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

310

2288

1.38

6.54

1.2

iu/ml

79.9

147.3

3.88

102

840

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

719

5953

1.24

6.47

1.3

1.2

u/ml

11.6

12.6

0.13

243

2274

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.07

6.45

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

3.40

6.41

1.6

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.06

6.35

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

142

2.55

6.34

1.3

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.25

6.27

1.4

2.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.00

6.22

1.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

4.68

6.21

4.6

2.2

u/field

0.6

0.7

0.03

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

496

1.79

6.20

1.4

1.2

u/ml

8.9

4.8

0.58

164

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

147

949

1.57

6.19

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

391

1.88

6.06

1.5

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.88

6.03

1.3

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.30

6.02

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

15.02

5.90

2.9

2.8

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.12

5.88

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

243

2.11

5.88

1.2

1.5

umol/l

14.6

12.8

0.68

224

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

167

2.35

5.80

1.2

1.1

u/l

1.0

1.1

2.44

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

152

1004

1.53

5.80

1.2

1.3

u/ml

36.9

35.7

—

(3017509) Phencyclidine [Presence] in Urine

5.51

5.80

1.5

1.2

—

(4027681)

180

2.29

5.77

1.4

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

286

2130

1.36

5.74

3.9

3.7

u/ml

62.9

65.0

0.06

276

2052

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

392

1.85

5.70

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

2.97

5.67

2.1

2.2

e6/l

176.9

147.7

0.18

(3014051) Protein [Presence] in Urine by Test strip

131

846

1.56

5.55

3.0

2.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

236

2.09

5.52

1.2

1.1

mg/l

43.0

37.7

0.37

187

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

178

2.26

5.47

1.5

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

451

1.76

5.38

1.1

126.1

116.9

1.19

407

(3000034) Microalbumin [Mass/volume] in Urine

309

1.92

5.29

3.6

2.5

mg/l

115.6

22.6

1.13

223

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.86

5.25

1.1

1.3

u/l

262.3

127.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.86

5.25

7.4

5.6

—

(3044941) Cell count panel - Synovial fluid

583

1.66

5.25

1.6

1.4

—

(4281824)

443

1.75

5.13

1.4

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

114

729

1.58

5.07

1.2

u/ml

55.5

43.3

0.28

(1761868) Lipid panel - Serum or Plasma

1086

12267

0.85

5.05

3.5

2.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

615

0.42

4.95

1.6

1.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.04

4.94

7.8

7.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

227

2.04

4.90

1.1

mg/l

277.7

267.3

0.14

191

(3001019) Free T4 and TSH panel - Serum or Plasma

103

1593

0.64

4.87

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.99

4.82

1.1

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.79

4.81

1.3

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

101

2.58

4.79

1.3

1.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

150

2.28

4.78

1.5

1.4

57.3

66.9

0.82

123

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

137

925

1.50

4.78

1.2

1.3

u/ml

12.2

5.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

9.01

4.78

2.9

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

5.01

4.77

1.3

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

285

1.90

4.77

1.6

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

499

1.68

4.75

2.4

2.1

mg/l

36.2

23.1

0.67

125

(3007461) Platelets [#/volume] in Blood

4309

42084

1.24

4.73

48.1

19.6

e9/l

257.3

249.8

8.88

4225

40820

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.79

4.70

2.0

2.5

mmol/l

7.6

7.5

0.04

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

108

2.51

4.70

1.3

1.1

—

(3024731) MCV [Entitic volume]

4309

42096

1.24

4.64

48.0

19.6

91.6

91.2

5.38

4254

41330

(3025549) Creatine [Moles/time] in 24 hour Urine

4.15

4.62

1.3

—

(3048879) Bone marrow aspiration report

115

2.44

4.62

1.7

2.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

103

2.53

4.62

1.3

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

116

763

1.53

4.59

1.3

1.2

u/ml

3.5

4.4

—

(3026361) Erythrocytes [#/volume] in Blood

4309

42102

1.24

4.59

48.2

19.6

e12/l

4.2

4.5

136.68

4211

40698

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

14.02

4.57

8.3

6.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

137

935

1.48

4.56

1.3

u/ml

6.0

5.6

0.06

166

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

8.19

4.56

5.8

1.8

—

(3035941) MCH [Entitic mass]

4308

42097

1.24

4.55

48.0

19.5

30.4

30.3

1.96

4253

41328

(3000963) Hemoglobin [Mass/volume] in Blood

4309

42112

1.24

4.52

48.6

19.7

g/l

127.2

134.5

162.87

4257

41354

(4268621)

342

1.79

4.48

2.5

2.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

263

1.91

4.48

4.4

4.1

u/ml

313.0

132.5

—

(4306422)

477

1.67

4.47

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

394

1.74

4.47

1.5

1.4

u/l

21.4

30.7

1.33

325

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

117

2.40

4.46

1.2

1.1

miu/ml

1579.6

1555.5

0.04

117

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

3.27

4.46

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

105

2.48

4.45

1.3

1.0

—

(3010813) Leukocytes [#/volume] in Blood

4308

42112

1.23

4.44

48.3

19.6

e9/l

7.4

6.7

33.80

4215

40687

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

288

2236

1.31

4.42

2.0

1.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

156

2.19

4.39

1.1

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.72

4.36

1.3

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.51

4.35

1.0

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.51

4.33

1.3

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.34

4.32

1.1

1.3

nmol/l

9.9

665007.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

2.44

4.29

1.3

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

340

1.77

4.27

1.1

100.9

94.9

0.95

323

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

401

1.71

4.22

1.5

nmol/l

0.3

0.10

304

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.84

4.22

1.4

12.0

10.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

206

2.00

4.20

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

364

1.74

4.20

3.5

4.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

342

1.76

4.19

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

200

2663

0.74

4.19

1.3

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

193

2.03

4.17

2.7

1.8

u/field

1.1

4.2

1.55

120

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

519

1.61

4.13

2.0

1.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

103

2.43

4.12

1.0

1.1

78.8

85.2

0.31

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

103

2.43

4.12

1.0

1.1

85.0

85.7

0.02

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.99

4.12

7.8

7.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

613

5233

1.20

4.04

16.2

6.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

316

2518

1.27

3.99

2.1

1.9

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.13

3.92

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.13

3.92

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.13

3.92

1.0

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

178

2.03

3.88

1.2

1.5

ug/l

8.0

0.01

157

(3024869) Neuronal Ab [Presence] in Serum

2.97

3.84

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

545

1.57

3.83

1.3

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.54

3.79

1.2

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

12.01

3.76

6.2

5.2

umol/l

480.5

399.8

—

(3002619) Bacteria identified in Specimen by Culture

2.65

3.72

1.1

1.2

—

(4015189)

109

2.30

3.68

2.8

2.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

103

2.34

3.66

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.69

3.65

1.1

74.9

79.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.69

3.65

1.1

58.0

76.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

162

2.04

3.64

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

156

2.06

3.60

6.1

6.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

444

1.61

3.58

1.2

1.3

u/ml

34.9

37.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.95

3.57

1.1

mmol/l

0.9

2.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

171

2.00

3.53

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

338

1.69

3.53

2.3

2.2

u/field

2.5

2.3

0.11

102

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

305

2460

1.26

3.52

2.3

2.4

au/ml

16.5

23.3

—

127

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.54

3.46

1.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

252

1.79

3.40

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

174

1.96

3.38

2.3

3.0

41.5

39.3

0.29

(3045424) Erythrocytes [Presence] in Urine

660

1.48

3.37

1.7

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

120

2.17

3.37

2.0

1.7

—

(3026480) Teichoate Ab [Titer] in Serum

3.71

3.35

1.2

1.1

—

(4146454)

351

1.66

3.35

2.6

2.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

240

1.80

3.30

1.2

1.3

mmol/l

10.7

11.9

0.36

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.92

3.29

1.4

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.92

3.29

1.1

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.92

3.29

1.4

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

486

1.55

3.28

1.0

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

8.58

3.26

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

2.30

3.26

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.78

3.25

1.9

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.67

3.22

1.1

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.67

3.22

1.1

1.2

100.4

99.0

0.08

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

250

1.77

3.19

1.1

—

(3025315) Body weight

5.34

3.19

5.5

3.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

595

1.49

3.18

1.7

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

251

1.76

3.15

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

111

2.17

3.12

1.4

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

252

1.75

3.11

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

252

1.75

3.11

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

260

1.74

3.09

3.1

2.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

140

2.01

2.99

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.29

2.99

1.0

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

4.29

2.99

12.4

8.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

10.01

2.98

1.4

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

265

1.70

2.91

1.7

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

250

1.73

2.91

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.32

2.90

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

163

1248

1.32

2.88

1.5

1.3

iu/l

25.7

32.2

1.73

133

1068

(44806420)

115

2.09

2.88

2.4

—

(3002256) Pathology report gross observation

582

5093

1.16

2.87

1.3

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

6.67

2.86

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

109

2.12

2.84

1.2

1.7

ug/l

10.2

8.4

0.60

109

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

179

1.85

2.81

1.2

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

179

1.85

2.81

1.2

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

179

1.85

2.81

8.2

15.9

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

165

1.88

2.80

1.8

2.6

u/l

232.1

206.6

0.85

165

(3016273) Islet cell 512 Ab [Units/volume] in Serum

4.45

2.79

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.55

2.78

2.5

1.3

ng/l

111.8

110.5

0.02

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

8.34

2.75

1.2

4.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

8.34

2.75

5.2

4.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

8.34

2.75

5.6

5.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

8.34

2.75

2.8

1.0

mmol/l

4.6

4.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

159

1.89

2.75

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

409

0.49

2.74

1.7

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

104

2.12

2.74

1.3

113.1

111.8

0.08

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.43

2.70

1.1

1.2

mmol/l

1.5

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

3.13

2.64

1.0

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

220

1.73

2.64

2.1

1.5

g/l

0.9

0.10

220

(3019832) Treponema pallidum Ab [Presence] in Serum

262

2154

1.23

2.62

1.7

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

549

6232

0.87

2.61

2.9

3.1

ug/l

0.8

0.10

388

4229

(3047352) Trisomy 18 risk [Likelihood] in Fetus

401

0.50

2.60

1.6

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

120

2.01

2.60

1.2

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

4.67

2.59

1.9

1.3

umol/24h

431.3

331.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

386

1.54

2.55

1.3

e6/l

27749.6

101913.2

1.69

273

(40757373) Influenza virus identified in Isolate

2.36

2.55

1.5

1.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.46

2.54

1.5

2.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.03

2.52

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.11

2.48

1.6

1.3

28.8

31.8

0.14

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.67

2.45

7.3

7.5

—

(3014891) Appearance of Pleural fluid

2.67

2.45

1.6

1.4

—

(40762814) Titanium [Mass/volume] in Blood

2.24

2.43

1.9

2.1

ug/l

3.5

3.9

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.95

2.41

1.1

—

(3022689) Creatine [Moles/volume] in Urine

2.17

2.40

1.9

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3635

35436

1.11

2.38

4.5

3.8

mmol/l

1.4

1.3

16.70

3279

31784

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

6.25

2.37

1.2

1.1

umol/l

262.6

136.6

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

6.25

2.37

1.0

1.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.64

2.36

2.4

2.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.50

2.35

1.2

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

451

1.47

2.35

1.1

u/ml

2.9

3.7

0.32

192

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

901

0.68

2.34

1.5

—

(3005033) Fetal Nuchal fold Thickness US

398

0.53

2.33

1.6

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

199

1.71

2.31

1.1

ratio

1.0

0.16

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.31

2.6

1.1

—

(3024263) Appearance of Synovial fluid

215

1.68

2.28

2.1

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

381

1.50

2.27

2.0

1.5

19.4

31.3

2.63

230

(40768443) Skin Pathology biopsy report

213

1744

1.23

2.25

1.3

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.02

2.25

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

156

1.80

2.25

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

449

1.45

2.21

1.4

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.78

2.20

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.78

2.20

1.1

1.3

76.4

70.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

143

1.82

2.18

1.2

1.1

ng/l

81.0

273.9

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.69

2.15

1.0

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.21

2.10

1.7

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

190

1.69

2.09

2.3

1.5

2.2

4.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.56

2.09

1.2

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1179

0.74

2.08

2.2

1.7

mg/l

3.4

4.0

0.29

830

(40768800) Prostate Pathology biopsy report

689

0.66

2.06

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

212

1755

1.22

2.05

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

516

0.62

2.01

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.08

2.01

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.63

2.01

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

517

5780

0.88

1.99

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

281

1.54

1.94

1.2

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.57

1.92

1.2

1.0

—

(3045142) Bone marrow Pathology biopsy report

389

1.44

1.90

1.5

1.3

—

(3000492) Spirometry study

376

3300

1.15

1.85

1.6

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

100

1.90

1.85

1.2

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

116

915

1.27

1.76

1.4

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1053

9829

1.09

1.75

1.8

1.6

mmol/l

1.5

1.3

6.37

881

8115

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.34

1.74

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.34

1.74

1.0

1.5

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.98

1.74

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.98

1.74

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.98

1.74

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.98

1.74

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

484

0.64

1.74

1.6

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.50

1.74

1.0

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

483

0.64

1.72

1.6

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.13

1.71

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

481

0.64

1.70

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

481

0.64

1.70

1.6

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.16

1.66

2.7

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.80

1.65

1.4

1.1

u/l

9.6

21.4

—

(4024509)

418

1.39

1.64

1.8

1.6

—

(3006462) Nitrate [Presence] in Urine

181

1.61

1.63

4.1

3.8

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.57

1.61

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.50

1.59

1.4

—

(4211845)

198

1.57

1.59

4.0

3.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.00

1.58

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

362

0.61

1.57

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

110

878

1.26

1.55

1.2

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

3.34

1.52

1.0

1.7

nmol/l

16.0

9.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

547

4983

1.11

1.52

4.8

4.3

33.4

33.0

0.42

377

3241

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.86

1.50

1.9

3.7

au/ml

149.0

46.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

428

0.65

1.47

1.2

1.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.25

1.40

33.0

7.6

—

(4133840)

1.85

1.40

1.5

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.18

1.39

1.2

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

2.04

1.32

2.1

1.6

—

(4094501)

994

0.79

1.28

1.1

—

(21494434) Karyotype in Bone marrow

327

1.38

1.27

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.09

1.27

1.2

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1203

0.81

1.27

1.4

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.82

1.25

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.97

1.22

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

807

8588

0.93

1.19

4.0

4.3

20.8

21.8

0.91

370

4400

(3027035) Albumin [Mass/time] in 24 hour Urine

2.31

1.18

1.3

1.2

—

273.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

127

1067

1.20

1.17

1.9

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3848

37941

1.07

1.16

5.4

4.7

mmol/l

2.5

2.8

65.88

3500

34333

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.34

1.12

4.3

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

158

1362

1.17

1.10

2.0

1.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

244

2170

1.13

1.09

2.2

2.1

nmol/l

10.3

12.9

4.90

202

1931

(3022475) Manganese [Moles/volume] in Blood

2.38

1.09

1.0

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.82

1.08

1.0

1.2

—

117.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.19

1.08

1.1

1.2

—

(4212803)

2.12

1.05

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.12

1.05

1.3

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

278

2499

1.12

1.05

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

369

0.70

1.01

1.5

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.77

1.00

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

485

1.26

0.98

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.18

0.98

4.0

4.7

—

(44813793)

232

1.38

0.97

1.2

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.14

0.91

2.2

2.6

—

(3000285) Sodium [Moles/volume] in Blood

1.75

0.90

1.5

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

106

904

1.18

0.88

1.7

1.5

pmol/l

156.4

171.5

0.19

101

882

(3047007) Chlamydophila sp Ab [Presence] in Serum

466

1.25

0.88

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

281

1.32

0.86

1.4

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

310

0.71

0.85

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.94

0.84

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

827

1.18

0.83

1.2

1.3

miu/ml

201.8

216.8

0.13

377

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.77

0.0

1.0

—

(3008898) HLA-B27 [Presence]

125

1095

1.15

0.77

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.52

0.75

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

119

1041

1.15

0.75

2.1

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.64

0.75

1.1

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.60

0.74

1.3

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.60

0.74

4.8

6.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.08

0.74

1.0

—

(44806071)

1.84

0.73

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.00

0.72

2.6

5.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

195

0.67

0.72

1.1

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.67

0.72

3.1

2.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.71

0.70

1.3

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.55

0.69

1.0

—

(3001729) Color of Synovial fluid

1.67

0.68

1.1

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.67

0.68

1.4

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

582

0.82

0.66

1.6

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.72

0.64

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3745

37097

1.04

0.60

4.9

4.2

mmol/l

4.4

4.7

55.59

3417

33790

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

198

0.71

0.60

1.3

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

163

0.67

0.60

1.2

1.1

u/ml

0.5

0.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

219

0.73

0.57

1.1

iu/ml

12.1

11.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.48

0.57

1.8

3.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

132

1.37

0.57

1.3

1.2

g/l

36.6

39.9

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

176

1.31

0.56

2.1

2.2

ug/min

145.2

89.3

—

(40758292) HTLV I+II Ab panel - Serum

1.46

0.56

1.5

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.62

0.55

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

206

0.73

0.55

1.0

1.1

—

(4034850)

138

1250

1.11

0.55

16.7

9.2

—

(40768795) Lymph node Pathology biopsy report

385

1.20

0.54

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

125

1.36

0.53

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

136

0.66

0.51

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3710

36798

1.04

0.48

4.9

4.2

mmol/l

1.4

1.5

20.57

3363

33307

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

110

0.64

0.48

1.9

1.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

119

1.35

0.48

1.7

1.4

—

(3034426) Prothrombin time (PT)

111

1.35

0.46

1.6

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

1.61

0.43

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

322

1.18

0.42

1.7

1.5

—

(3019174) dRVVT (LA screen)

1.56

0.42

1.0

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.56

0.42

1.4

2.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.52

0.41

1.4

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.41

0.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

105

1.33

0.41

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

399

1.15

0.39

1.3

mmol/l

8.3

7.5

0.80

288

(3015183) Erythrocyte sedimentation rate

160

0.75

0.39

1.3

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

160

0.75

0.39

1.2

1.0

u/ml

9.5

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

215

0.79

0.39

1.2

1.4

pmol/l

53.3

203.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

542

1.13

0.38

1.1

u/ml

2.5

1.9

0.12

229

(3025130) Human papilloma virus identified in Specimen

448

1.14

0.38

1.6

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

564

5458

1.04

0.35

1.5

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

245

1.18

0.35

1.3

1.5

ug/l

1.6

4.3

1.73

200

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1055

0.92

0.34

1.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.36

0.34

2.5

2.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

305

0.85

0.31

1.2

1.1

u/ml

0.2

0.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

183

0.82

0.27

1.1

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

122

1.23

0.27

3.5

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

373

3841

0.97

0.23

1.6

—

(3003338) MCHC [Mass/volume]

3154

31355

1.02

0.22

42.5

17.3

g/l

331.3

331.7

1.99

3129

31060

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.16

0.21

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

241

1.12

0.19

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

482

1.08

0.18

1.1

u/ml

1.9

5.4

2.97

260

(3013293) Extractable nuclear Ab [Presence] in Serum

1.17

0.17

2.0

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

459

1.07

0.14

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1080

10693

1.01

0.13

4.6

5.0

ug/l

3.6

3.8

0.08

935

9574

(3025577) Chromium [Mass/volume] in Blood

276

1.09

0.13

1.9

2.0

ug/l

1.8

2.2

0.33

228

(3020650) Glucose [Presence] in Urine

107

0.84

0.13

1.3

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

462

1.06

0.12

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

462

1.06

0.12

1.1

u/ml

3.1

0.8

0.40

217

(3051387) C reactive protein [Mass/volume] in Capillary blood

797

1.04

0.11

4.3

3.4

mg/l

23.6

28.5

0.87

480

(40768793) Breast Pathology biopsy report

982

0.97

0.10

1.4

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

253

1.07

0.08

1.0

ng/l

761.7

739.7

0.11

161

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

254

1.06

0.07

1.0

ng/l

1603.6

345.1

0.43

168

(40765096) Chromosome analysis panel by Banding

122

0.90

0.07

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

437

0.96

0.06

1.2

1.1

u/ml

0.6

2.2

1.85

111

(1002224) Polysomnography panel

127

1247

1.02

0.06

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.11

0.05

1.1

u/ml

0.6

11.3

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

257

1.05

0.05

1.0

ng/l

31.7

47.4

0.96

167

(3023430) Cat dander IgE Ab [Units/volume] in Serum

337

1.04

0.04

1.1

u/ml

3.8

4.4

0.13

137

(3014133) Dog dander IgE Ab [Units/volume] in Serum

367

0.98

0.01

1.2

1.1

u/ml

2.6

3.0

0.10

142

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

562

1.00

0.00

1.8

pmol/l

173.3

206.6

1.67

534

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

144

0.97

0.00

1.6

1.3

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.8

—

32.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.96

0.00

8.6

1.7

—

(4038314)

0.00

0.0

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.85

0.00

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.96

0.00

1.3

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPOKALAEMIA and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_HYPOKALAEMIA	2.339 [2.11, 2.59]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.411

During the follow-up period (1.1.1998 — 31.12.2019), 8934 out of 20756 females with E4_HYPOKALAEMIA died.

Males

Parameter	HR [95% CI]	p-value
E4_HYPOKALAEMIA	4.304 [3.73, 4.97]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 5287 out of 11180 males with E4_HYPOKALAEMIA died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPOKALAEMIA.

N-year risk	Females	Males
1	0.275%	0.845%
5	1.248%	4.493%
10	3.163%	11.026%
15	6.378%	20.024%
20	11.442%	31.02%

Relationships between endpoints

↥

Index endpoint: E4_HYPOKALAEMIA – Hypokalaemia

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hypokalaemia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints